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Abstract: Functional Outcome Measures in Haemophilia- A Systematic Review 
Maheshi Wijesekera 
Background: Haemophilia is an inherited bleeding disorder that results in haemarthrosis 
leading to chronic arthropathy in those with severe forms of the disease. It causes significant 
disability and affects a patient’s quality of life. Functional outcome measures enable the 
healthcare professionals to assess the patients’ ability to carry out activities of daily living 
providing an important input to the assessment of joint disease.  
Objectives: This study aims to carry out a systematic review to identify the existing functional 
outcome measures used in the adult English speaking, haemophiliac population and evaluate 
these instruments based on their development methodology, measurement properties and other 
properties. 
Methods: Both PubMed and Scopus databases were searched to identify suitable outcome 
measures. Once the search identified the instruments, each instrument was searched to identify 
the relevant pilot and validation studies. Development methodology of each instrument was 
summarised. The measurement properties were evaluated using the COnsensus-based 
Standards for the selection of health Measurement INstruments (COSMIN) 4-point checklist. 
These measurement properties included internal consistency, reliability, measurement error, 
construct validity, criterion validity, content validity and responsiveness. The other properties 
that were assessed include interpretability, generalisability, precision, conceptual model, 
measurement model, acceptability, feasibility and burden.  
Results: There were three main outcome measures used to assess function in the adult 
haemophiliac population. These were the Haemophilia Activities List (HAL), the Functional 
Independence Score in Haemophilia (FISH) and the Haemophilia Exercise Project–Test-
Questionnaire (HEP-Test-Q). Information on the development of instruments was only well 
provided in the HAL. However the COSMIN checklist proved that the HAL had not assessed 
all measurement properties. The FISH and the HEP-Test-Q, did not possess very good 
methodological quality of its measurement properties. With regards to the other properties, all 
three instruments were acceptable but interpretability was poor. The HAL and the HEP-Test-
Q were precise. The conceptual model instruments assessed function in different forms, 
whereas the measurement model was treated as a reflective model in all three instruments. The 
HEP-Test-Q had the most amount of burden in comparison to the other instruments. The main 
limitation of this study was that the FISH, a performance based instrument was evaluated using 
the COSMIN checklist that was developed to assess patient reported outcomes. 
Conclusion: This systematic review suggests that the existing instruments produced to assess 
function in adult persons with haemophilia have not been adequately validated and that the 
methodology undertaken for this process consists of certain drawbacks. This suggests that 
there is scope for a new instrument to assess function in the English speaking adult 
haemophiliac population.  
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Glossary of terms 
 
Acceptability The willingness or ability of patients from the target 
population to complete the questionnaire. 
Clinimetrics The measurement of clinical phenomenon by an 
instrument. 
Concept The specific goal of the instrument or the global event that 
is being measured.  
Conceptual 
framework/ model 
A schematic representation of the theory, explaining the 
underlying phenomena between items, domains, 
subconcepts, concepts and the scores produced by the 
instrument.  
Construct Well defined and precise subject of measurements that are 
usually unobservable characteristics 
Construct validity The extent to which an instrument validly measures the 
construct meant to be measured. 
Content validity  The ability of an instrument to reflect the construct being 
measured in its content.  
Criterion validity Extent to which a score of an instrument reflects the score of 
its ‘gold standard’. 
Cross-cultural 
validity 
Ability of items to mirror the performance of the translated 
or culturally adapted instrument to the original instrument 
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Face validity  The extent to which the items of an instrument represents the 
construct being measured. 
Feasibility This assesses the burden of an instrument on the healthcare 
professional.  
Instrument A method to capture data which may take the form of a 
questionnaire as well as the information and documentation 
that support its use.  
Internal 
consistency 
The extent to which the items are interrelated. 
Interpretability The extent to which a person can accredit qualitative 
meaning to the score of an instrument.  
Item An individual question, statement or task that is evaluated to 
address a particular concept.  
Measurement 
model 
Measurement models depict the causal relationships 
between the construct measured and its items.  
Precision   The ability of a score of an instrument to make distinctions. 
Psychometrics  The field of study concerned with the theory and technique 
of psychological measurement. 
Responsiveness  The ability of an instrument to detect change over time in 
the construct to be measured. 
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Structural validity The extent to which the dimensionality of the construct 
being measured is reflected by the scores of the instrument. 
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1 CHAPTER 1- Introduction 
 
1.1 Haemophilia 
1.1.1 Disease overview  
Haemophilia is an inherited bleeding disorder and is the most common of all the severe 
bleeding disorders. It is caused by a deficiency of a single clotting factor; factor VIII 
in haemophilia A (Classic haemophilia) and factor IX in haemophilia B (also known 
as Christmas disease) comprising 85% and 15% of cases respectively. It follows an X-
linked recessive mutation thus predominantly affects males.1 In the absence of a family 
history the rate of spontaneous mutations is 30%.2 The carriers of this condition 
(females) lack about 50% of the respective clotting factor but this suffices for normal 
clotting to take place. About 10% of carriers may have less than 50% of normal amount 
of factor making them more susceptible to bleed especially after surgery or trauma.3, 4  
 
 
 
 
 
 
 
 
 
 
Female unaffected 
Male unaffected 
Female carrier 
Male affected 
Figure 1 Pedigree diagram of inheritance pattern of haemophilia 
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A rare form of haemophilia that results from a lack of factor XI is haemophilia C (also 
known as Rosenthal syndrome). This is thought not to be a ‘true’ haemophilia as it is 
an autosomal recessive condition and affects both males and females equally.5 This 
condition is not usually associated with spontaneous haemarthrosis.6 Another form of 
the disease that does not carry a genetic predisposition is, ‘acquired haemophilia.’ It is 
caused by autoantibody production against Factor VIII and presents with bleeding but 
in later life. Acquired haemophilia predominantly involves skin bruising and soft tissue 
bleeding whereas haemarthrosis is unusual.7 In about 50% of acquired haemophilia 
cases the cause is unknown although the known causes include drug interactions, 
cancer, immune disorders and  pregnancy or post-partum.8  
The deficiency of coagulation factor in haemophilia results in the patient being more 
likely to bleed, often without an apparent cause and this can occur in one site or 
multiple sites. Prior to treatment availability congenital haemophilia most commonly 
affects the musculoskeletal (80%) and central nervous systems (20%) and results in 
various complications which will be explained further below.9  
Further discussion is limited to haemophilia A and B. 
1.1.2 Historical perspective 
Historical writing on haemophilia dates back to the Rabbinic writings in Judaism in 
the 2nd Century AD. This disease was later considered a ‘royal disease’ as Queen 
Victoria was a carrier of haemophilia B, which resulted in some of her royal 
descendants across the continent such as Russia, Germany and Spain, inheriting the 
disorder.10, 11  
1.1.3 Epidemiology 
Haemophilia has an average prevalence of one per 10,000 of the population.9 More 
specifically, incidence among males is 1 in 5,000 for haemophilia A and 1 in 30,000 
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for haemophilia B.2 According to the United Kingdom (UK) survey statistics in 2014, 
the number of persons diagnosed with haemophilia was 6811, out of which 5646 had 
haemophilia A and 1165 persons had haemophilia B.12 Haemophilia has no particular 
affinity towards a certain race or ethnic group.13, 14  
1.1.4 Classification 
Classification of persons with haemophilia is based on the level of coagulation factors 
present in blood. The normal reference range for factor levels in blood is 50-150 IUmL-
1 (50%-150%).  Mild haemophilia is associated with a factor activity of 0.06-0.40 
IUmL-1 (6%-40%), whereas moderate and severe haemophilia are associated with 
factor activity levels of 0.01-0.05 IUmL-1 (1%-5%) and of <0.01 IUmL-1 (<1%) 
respectively.15 These levels of factor generally remain unchanged throughout life. 
Mild forms of the disease may go undiagnosed if they do not manifest as symptoms 
although the level of factor present in the blood is low.16 17 
1.1.5 Clinical course 
Families with a known background of the disease will be offered appropriate testing 
on every male child due to the inheritance pattern of this disease.  When facilities are 
available the investigations are arranged antenatally including genetics that partly 
involves screening of male relatives. For patients who present with certain signs of the 
disease but in the absence of a family history, a new mutation would be tested for. 
Features in the undiagnosed neonate can range from intracranial haemorrhage, extra-
cranial haemorrhage, bleeding from puncture sites, internal bleeding, haemarthrosis, 
bleeding from the umbilical stump or bleeding following circumcision. In such 
neonates, it is imperative to carry out investigations in order to seek a diagnosis.18 
Assays of factors in clot formation usually form the basis of initial diagnosis.  
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As the severity of haemophilia increases, more intensive follow-up, where a 
comprehensive care program with frequent clinical and laboratory review is carried 
out.19 In the UK, patients with severe or moderate disease should be offered a clinical 
or multidisciplinary review twice a year as a minimum whilst those with mild disease 
are assessed annually.19 With sufficient treatment and care as seen in most western 
nations, persons with haemophilia live near to normal lives indicating a good 
prognosis. However, without adequate treatment as observed in low-income nations, 
most children with severe disease will die young.20 
1.1.6 Complications 
1.1.6.1 Overview 
As patients with haemophilia are prone to bleeding, the clinical features are associated 
with bleeding from the respective body system. Patients with severe haemophilia 
suffer with spontaneous bleeding of joints and other tissues while those with moderate 
disease suffer with less spontaneous bleeding but still remain at a high risk of bleeding 
after minor trauma.  Whereas those with mild disease are only susceptible to bleeding 
after major trauma.17 Post traumatic bleeding after dental or  other surgical procedures 
are seen.21 The central nervous system may be affected as these patients have an 
increased risk of intracranial bleeds after traumatic injury.22  
The complications of haemophilia are closely linked with the musculoskeletal system 
and consist mainly of haemarthrosis and less commonly pseudotumours resulting in 
fractures.23, 24 Pseudotumours are a clinical entity caused by chronic encapsulated 
haematomas. This rare phenomenon may be of osseous or soft tissue origin and result 
in the destruction of adjacent structures depending on the anatomic site.25 Gilbert et 
al26 described two distinct groups of pseudotumours. Proximal pseudotumors are seen 
in the adult population and originates in axial skeleton around the pelvis and proximal 
femur. Whereas distal pseudotumors predominantly affect the skeletally immature and 
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is caused by intraosseous bleeding in the cancellous bone.26The incidence of 
pseudotumors have decreased with better control of the disease.27 Persons with 
haemophilia who are immunocompromised due to associated comorbidities may be 
more susceptible to developing septic arthritis, soft tissue infections and low bone 
mineral density.28, 29  
The severity of haemophilia is often reflected in the clinical features exhibited such as 
spontaneous haemarthroses accompanied by functional impairment seen in the severe 
form of the disease. In mild haemophilia, as bleeding is only likely to follow trauma 
or surgery, these patients are treated as and when they present. These patients have 
very minimal functional impairment caused by their haemophilia.30, 31  
Patients with haemophilia not only suffer from the obvious physical symptoms but 
also have psychosocial issues associated with the genetics, severity and chronicity of 
the disease. The psychological manifestations can include poor self-esteem, anxiety 
and stress as a result of various factors such as social restrictions due to financial 
difficulties.32   
1.1.6.2 Haemarthrosis 
Haemarthrosis is important as it is the most common complication of severe 
haemophilia and if treated inappropriately, can result in highly disabling morbidity 
such as chronic arthropathy and flexion deformities.24, 33 Generally joints have a higher 
tendency to bleed because there are low levels of tissue factor, a crucial component for 
haemostasis within the joints. This, combined with a lack of either factor VIII or factor 
IX results in a higher tendency to bleed into the joints.34, 35 Prior to the availability of 
current treatments for the disease, haemarthrosis  could occur up to twenty times a year 
in those with severe disease.36  
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1.1.6.2.1 Target joint 
Most patients with haemophilia who experience recurrent haemarthrosis are said to 
develop a target joint, where initial destruction of a joint will take place. Such a target 
joint is more likely to develop in patients with severe disease than those with moderate 
or mild haemophilia. Those with severe disease may also have more than one target 
joint.37, 38 There are multiple definitions used for a ‘target joint’ as defined by various 
organisations.39-41 The International Society of Thrombosis and Haemostasis defines a 
target joint as “three or more spontaneous bleeds into a single joint within a 
consecutive 6 month period”.42 This group further goes on to say that if there are less 
than 2 bleeds into a joint over a consecutive 12 month period it is no longer known as 
a target joint.42 
These target joints are more susceptible to develop chronic synovitis and cause damage 
to both cartilage and bone. Haemarthrosis most commonly affects the knees, ankles 
and elbows. Other joints such as hips and shoulders are rarely affected, showing a 
preference towards the weight bearing joints.23 The appearance of deformity caused 
by chronic contractures in haemophilic arthropathy may take the form of an equinus 
deformity in the ankle, or a flexion contracture involving the knee or elbow joints.24  
1.1.6.2.2 Pathophysiology 
Haemophilic arthropathy occurs in three stages, it is initially set off by acute 
haemarthrosis which results in chronic synovitis and finally progresses to degenerative 
arthritis.43 During the acute insult of haemarthrosis, the pathological process manifests 
itself as joint capsular distension and vasodilatation of the capsular and epiphyseal 
bone vessels, resulting in destruction of these structures. The disintegration of the 
cartilage occurs with recurrent haemarthroses.44 The pathogenesis that follows this is 
incompletely understood. It is thought that the iron present in red blood cells plays a 
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pivotal role in the inflammatory process.43, 45 The breakdown product of haem, 
haemosiderin initiates the production of pro-inflammatory cytokines; particularly 
interleukins 1, 6 and tumour necrosis factor-alpha.46-49 Furthermore, it induces genes 
that are present in the synovial tissue such as Mouse Double Minute 2 homolog 
(MDM2) that results in cellular proliferation as seen in synovitis.50  
Following the development of haemarthrosis, the synovium attempts to reabsorb 
excess blood, thereby resulting in hypertrophic and fragile synovial lining with an 
increased tendency to rebleed. The target joint contains abundant vascular and 
hypertrophic tissue which have a tendency to become impinged between articular 
surfaces and has a higher affinity to bleed resulting in a vicious cycle of haemarthrosis-
synovitis-haemarthrosis43, 51 The blood and the inflammatory mediators that are 
released into the joint interferes with the homeostasis of articular cartilage especially 
if not aspirated early.51-57 The synthesis of proteoglycans by chondrocytes are affected 
by the presence of intra-articular blood, leading to the apoptosis of chondrocytes.24 
Haemophilic arthropathy bears resemblance to osteoarthritis and rheumatoid arthritis, 
with regards to the progressive degeneration, inflammation of hyaline cartilage and 
synovial hypertrophy. The mentioned phenomenon progresses until the joint is 
completely destroyed.51, 58, 59  
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Figure 2 Pathophysiology of haemophilic arthropathy 
 
1.1.6.2.3 Epidemiology 
The chronic degenerative changes explained above affect 90% of persons with severe 
haemophilia whereby 1-6 major joints are affected by the age of 20-30 years.24 The 
Range of Motion (ROM) in joints is affected in almost 85% of the patients with the 
severe disease.43, 60 In the United States, 36% of those with severe haemophilia 
reported needing assistance with mobilising and 21% with haemophilia missed either 
school or work (mean of 10 days per year) due to their joint problems.61 These high 
levels of functional impedance suggest that preventative intervention is of paramount 
importance.  
1.1.6.2.4 Clinical manifestations 
Symptoms associated with acute haemarthrosis are tingling, limited ROM and pain at 
the affected joint that is generally followed by rapid joint swelling and bruising. In 
weight bearing joints, weight bearing may be impossible. On examination there may 
be ecchymosis, with a local increase in temperature and tenderness with the joint 
usually held in a flexed position.62, 63  
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Arthropathy presents with a myriad of symptoms that greatly affects the patient’s 
quality of life.23, 38, 60, 64, 65 Recurrent haemarthrosis may lead to muscle atrophy, 
ankylosis, reduced ROM and eventually arthropathy.66, 67 Arthropathy, once 
established is progressive and irreversible.68  
1.1.6.3 Psychosocial aspects 
The psychosocial challenges in congenital haemophilia are observed at three levels. 
Those that come with the diagnosis and treatment of haemophilia, the impact on the 
individual with haemophilia, and the impact on family life and social challenges 
encountered.69  
The challenges surrounding the diagnosis and treatment of haemophilia have reduced 
over the years with the availability of prophylaxis and home treatment in developed 
nations.69 However, challenges remain such as the use of blood products due to 
concerns over the transmission of infections and prion disease as portrayed in the 
media.70, 71 In families that have not encountered haemophilia before, the initial 
diagnosis not only affects the emotional wellbeing of the family but also financially.69 
Parents of those initially diagnosed with haemophilia, often experience a prolonged 
stage of denial or withdrawal thereby affecting their wellbeing.  
Persons with haemophilia experience anxiety surrounding the increased risk of 
bleeding, chronic joint pain and reduced function.69 In the cohort who have contracted 
Human Immunodeficiency Virus (HIV) or Hepatitis C (HCV) patients often 
experience depression due to associated comorbidities as well as the stigma attached 
to these conditions.72 During their childhood persons with haemophilia may 
experience low self-esteem and may feel isolated due to the fear of inducing a bleed.73  
Mothers of persons with haemophilia frequently experience guilt for passing on the 
disease and play a significant role in the disease management of their children.74 This 
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guilt may result in frustration or depression and as a consequence may result in 
rejection or overprotection of the child.75 With the main focus of the family being the 
person with haemophilia, other siblings may feel neglected and this may have an 
impact on the family dynamics.74, 76, 77 A new diagnosis of haemophilia in some 
families may negatively affect relationships between parents or even lead to 
abandonment by the father .69 
Reproductive technology may offer the opportunity to screen for an affected male with 
haemophilia among carriers and consequently aid in decision making amongst 
pregnant mothers. In cultures where this may not be executed and where cultural 
shaming for having a child with a disability take place, affected families will conceal 
the diagnosis in order ensure that their daughter is able to marry.78 
The psychosocial issues in persons with haemophilia are similar to other chronic 
disease, but certain characteristics are unique to haemophilia. The unpredictable nature 
of bleeding, its associated complications and the psychological burden on the 
carriers.73 The severity of the psychosocial impact in these three categories varies 
across the severity of the disease and in the presence of inhibitors.79 Therefore it is 
crucial to provide psychosocial support early on not only to the patient but also their 
families.  
 
1.1.7 Management of haemophilia 
1.1.7.1 Overview 
The conventional method of treatment consists of intravenous replacement of the 
deficient factor using commercially prepared factor concentrates. The two mainstays 
of treatment are ‘on-demand’ therapy and prophylaxis. ‘On-demand’ therapy is when 
factor concentrate administration takes place after a bleeding event. Prophylaxis is the 
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administration of treatment in the absence of bleeding with an aim of preventing any 
episodes of bleeding and can be given in the short-term or long-term.  
Regardless of the definition used for a target joint, it results in delayed diagnosis of 
the affected joint. Thus long-term prophylaxis remains the gold standard treatment in 
those with severe disease in the western nations.16, 80 
1.1.7.2 Historical Perspective 
A therapeutic breakthrough for haemophilia arose with the introduction of 
cryoprecipitate in its treatment in the 1960s. The introduction of factor concentrates 
followed a decade later. These were associated with complications as blood products 
were not screened for infectious diseases such as HIV and HCV. Consequently those 
who received unscreened factor were predisposed to developing these infections.24 
This was followed by the introduction of screened blood products to minimize this 
effect.81, 82 There remains continuing concerns about the theoretical transmission of 
prion disease such as variant Creutzfeldt’s Jakob Disease (vCJD).83  
Prior to the introduction of blood screening, there were about 7250 persons with 
haemophilia. All those with severe haemophilia (n= 2262) were said to be diagnosed 
with HCV as a consequence of contaminated blood products.84 There were 1246 
persons with severe haemophilia diagnosed with HIV.84 Most of these patients were 
reported to have progressed to chronic liver disease and some patients were co-infected 
with HBV, HCV and/ or HIV. Since the introduction of HIV screening for blood 
products in 1985 the cases of HIV among persons with haemophilia started reducing. 
In 2006 there were about 360 patients in the UK with a diagnosis of HIV as a 
consequence of the treatment received for their bleeding disorder.19 (These numbers 
are not haemophilia specific.) Persons with haemophilia that are 
immunocompromised, often carry a higher risk of liver disease and carcinoma of the 
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liver that is increased by coinfection with HCV.85, 86 In addition persons with 
haemophilia that are immunocompromised have a significant risk of secondary 
malignancies such as lymphoma.87 
Since the introduction of highly active anti-retroviral therapy (HAART) the morbidity 
of HIV positive persons with haemophilia has decreased.84However the use of 
HAART come with side effects such as unusual bleeding in this population with 
protease inhibitors.88 
Current practice in the UK routinely offers vaccinations to persons with haemophilia 
against hepatitis A and HBV in order to prevent contraction of such viruses.89  
1.1.7.3 Treatment options 
Two main types of clotting factor concentrates are available including plasma derived 
clotting factor concentrates and recombinant factor concentrates. The plasma derived 
clotting factor concentrate requires screening for infectious agents while the 
recombinant factor does not, as the factor concentrates are produced using genetic and 
deoxyribonucleic acid (DNA) technology. Therefore recombinant factor remains the 
favourable treatment of choice as recommended by the United Kingdom Haemophilia 
Centre Doctors' Organisation (UKHCDO).19 This was introduced in the UK in 1999.  
Desmopressin a synthetic vasopressin analogue that can be administered 
intravenously, subcutaneously or as an intranasal spray to increase the release of factor 
VIII is used in the mild forms of the disease.16 In an attempt to halt blood loss, 
antifibrinolytics such as tranexamic acid or epsilon aminocaproic acid may be 
administered. This acts by preventing the formation of the fibrinolytic enzyme. This is 
often used for oral bleeds or after dental surgery.90 
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1.1.7.4 Treatment Regimens  
Initially, the management option used for haemarthrosis was, ‘on-demand’ therapy. 
This treatment regimen resulted in patients developing severe destruction of their 
joints by the age of 20 or 30 years. These trends observed by specialists led to the 
current treatment options of regular prophylaxis to reduce the incidence of 
haemarthrosis.  
Newly diagnosed haemophilia patients should receive primary prophylaxis by the 
second joint bleed or significant soft tissue bleed according to recommendations by 
the UKHCDO.91 Secondary prophylaxis, is when factor administration follows several 
articular haemorrhages.68   
The goal of prophylaxis is to prevent the development of associated complications 
such as chronic arthropathy. The advancement of therapeutic options in developed 
nations has seen self-administration at home as a popular option for those with 
haemophilia. Advantages associated with this treatment method are convenience and 
rapid access to the factor. This lowers the level of side effects and complications such 
as the frequency of haemarthosis and progression of arthropathy.91 Due to the financial 
burden and the mode of coagulation factors administration, primary prophylaxis is 
only recommended in developed countries. It is noteworthy that self-administration 
therapy is associated with a risk to patients who receive chronic intravenous therapy 
and includes the complications of an indwelling venous catheter. The majority of 
patients with haemophilia do not have access to self-prepared factor or hospital 
treatment as they come from low-income countries, thereby leaving these patients 
often treated ‘on-demand’ or remain untreated.24, 68  
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When haemophilic patients participate in strenuous activities such as sport, episodic 
prophylaxis where factor replacement is given for short period intervals, may confer 
benefit by avoiding unanticipated bleeds.63 
1.1.7.5 Epidemiology 
In the World Federation of Haemophilia (WFH) annual global survey in 2014, the 
percentage estimate of children who were on prophylaxis in the UK was 95% and the 
percentage estimate of those above the age of 18 who were on prophylaxis was 70%.12 
1.1.7.6 Inhibitor development 
Factor replacement is associated with the development of inhibitors, which are 
antibodies that render factor concentrates ineffective and therefore, may allow 
uncontrolled bleeding. Inhibitors may develop in about 30% of those with  
haemophilia A after administration of its factor concentrate although this may be 
transient in about half of those.19, 92 Such patients often have worsened complications 
of joint disease that result in poor Quality of Life (QoL).  
In patients who have developed inhibitors, the treatment of acute bleeding episodes is 
extremely difficult. In such situations, more factor replacement or a different type of 
clotting factor (such as recombinant factor VIIa) will be required. This increases the 
financial burden for the provision of adequate care for such patients.93 
1.1.7.7 Evolution of joint function with current treatment regimens 
As treatment regimens for haemophilia advanced in the developed world, there was a 
noticeable change in the observed joint function. In the past, patients were restricted 
from high intensity tasks such as sport, as an increased level of uncontrollable bleeding 
in the musculoskeletal system was observed.94 This was followed by a temporary 
period of immobilisation caused by the acute insult. As haemarthrosis usually begins 
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at a young age, immobilisation caused inadequate muscle growth.95 The functional 
capacity proved to be poor in these patients as there was minimal muscle bulk to 
compensate for the destructed joint.95-97 
The perception held regarding the limitation of physical activity has reformed with the 
availability of novel treatment regimens with patients being encouraged to participate 
in sport.98 This has been regarded as a good method of decreasing the incidence of 
haemarthroses. The concept of increased activity has led to the establishment of 
physiotherapy as a means for improving joint function.95 
1.1.8 Management of haemarthrosis 
1.1.8.1 Overview 
In spite of the regular factor replacement, haemarthrosis and arthropathy  can still 
develop as some articular bleeds and subclinical hemorrhages are unavoidable.24 There 
are two main stays in the management of haemarthrosis, both with aims to impede the 
development of arthropathy: 1) management of acute haemarthrosis 2) management 
of the recurrent haemarthrosis that is results in the development of chronic arthropathy. 
1.1.8.2 Management of acute haemarthrosis 
In an acute haemarthrosis, in persons with haemophilia, administration of the relevant 
factor concentrates is the first line treatment. This can be done at home in those who 
are able to self-administer. Adjuvant treatment with analgesia aims to relieve pain and 
restore movement.33 Arthrocentesis may be carried out following extreme episodes of 
haemarthrosis and should be performed once factor concentrate has been 
administered.99 Other recommended therapeutic measures involve physiotherapy that 
include rest, ice, compression and elevation, but their consequences and practicality 
should be taken into account. Physiotherapy is available in different forms, provides 
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well rounded rehabilitation following haemarthosis as it has an effect on decreasing 
the bleeding frequency, joint instability and improves ROM and muscle bulk.63, 100 
1.1.8.3 Management of chronic arthropathy 
The knee joint used to be the most commonly affected joint in persons with 
haemophilia but since the introduction of prophylaxis, the ankle joint has the highest 
incidence of haemarthrosis.101 This is thought to be due to the higher activity rate as 
patients have acquired the skill to administer prophylactic and treatment regimens 
from home, placing the ankle at a more vulnerable position.101 
Despite conservative management options being freely available, surgical intervention 
aims to correct deformity pertained to the joint. This highlights the importance of a 
multidisciplinary approach especially involving the haematologists and the 
orthopaedic surgeons.  
1.1.8.3.1 Non-operative Management 
The initial management of joint disease comprises the use of physiotherapy, orthotics 
and use of corrective devices.  
Physiotherapy can vary from hydrotherapy, strength training and balance strength, 
balance training, and isometric to isotonic exercises, ultrasound, pulsed short waved 
diathermy and sports therapy.102 In some cases where pain is severe, transcutaneous 
electrical nerve stimulation may be attempted as it may also help with reducing 
inflammation and improve mobility. Recent advancements in therapies such as the 
programmed sports therapy95 has also been implemented in some countries. 
Physiotherapy is vital not only in the prevention of haemarthrosis but also is 
responsible for the rehabilitation in severe arthropathy as well as in the post-surgical 
care. Advances in physiotherapy, such as programmed sports therapy have more 
recently been established in developed countries. This enables patients to carry out 
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regulated therapy independently at home.95 In low income countries where clotting 
factors are not widely available, physiotherapy plays a vital role as it is more 
economically feasible.  
The intra-articular injection of hyaluronic acid- a natural substance of the synovial 
fluid and cartilage has been recommended and has been used for the treatment of 
haemophilic arthropathy of the knee. This is a promising option in whom non-
operative therapy has failed and where surgical intervention is impracticable.103 
1.1.8.3.2 Surgical management 
Surgical intervention is often performed on those who present with arthropathy as a 
consequence of haemarthrosis. This may take the form of soft tissue procedures (i.e. 
synovectomy, release of muscle contractures), osteotomies and arthrodesis or total 
joint replacements in those with severe pain and disability.  
Synovectomy is a surgical procedure that is frequently performed on persons with 
haemophilia with chronic haemarthrosis and synovitis; the aim is to delay total joint 
replacements. This procedure involves excision of the inflamed and hypertrophic 
synovium in order to decrease the propensity of recurrent haemarthrosis in a particular 
target joint. Having an estimated 70-100% reduction in the frequency of 
haemarthrosis, synovectomy maximises the effects of medical treatment and averts the 
progression to symptomatic arthritis.104-108 Synovectomy may be performed as either 
surgical (open or arthroscopic), chemical or as radiosynovectomy.  Chemical 
synovectomy involves the injection of a chemically active agent. Whereas 
radiosynovectomy (radionuclide synovectomy) involves intra-articular injection of a 
radionuclide to induce fibrosis. Each method has its advantages as well as 
disadvantages but the success rates remain similar for each procedure.63 It should be 
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noted that even though success with synovectomies have been documented, it does not 
halt disease progression to arthropathy.  
Total joint replacements have been performed in persons with haemophilia where 
the joints focused on are the knee, hip, ankle, elbow and shoulder joints. Previous 
studies on knee arthroplasty indicate high rates of complications due to the mode of 
factor replacement (i.e. pulse infusion).109, 110 Recent studies using continuous infusion 
of factor concentrates, have shown a lower reported frequency of bleeding and pain 
related complications.28 
During the end stage disease arthrodesis may be performed to reduce pain especially 
in the ankles, although arthrodesis of other joints have also been reported.111  
 
 
1.2 Disability 
  
 
1.2.1 Overview and historical perspectives 
Disability, the inability to function normally, is a major health concern, and it is not 
restricted to one particular organ system. Common forms of disability are that of 
locomotion, special senses (hearing and vision) and psychological. It is often seen as 
an outcome of disease as well as a diagnosis.112 Functional status can be viewed from 
various aspects. In the past traditional models solely viewed function using a 
biomedical model.113 This has evolved over the years into using a disablement model 
that focuses on the loss of function with its association to activities of daily living 
114,115   
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1.2.2 Definitions and concepts 
Defining disability proves to be difficult due to very little consistency across 
definitions in literature. Most definitions mirror the conceptual elements that they are 
derived from.116 Due to the broad nature of the subject a good definition should be able 
to encompass all the categories of disability.  
A group of authors from the ‘Measuring Health and Disability in Europe’ 
consortium117 defined disability and addressed the drawbacks of existing definitions. 
It was defined as “ difficulty of a function/functions at the body, person, or societal 
level, in one or more life domains, as experienced by an individual with a health 
condition in interaction with contextual factors”117.   
1.2.3 Conceptual frameworks 
Various conceptual frameworks have been used to define and explain disability and/ 
or function, as it has been the case for disease or disorder. This is likely due to the lack 
of a single conceptual framework among medical disciplines. The introduction of a 
conceptual framework for disability was made during the 1960s-1970s.118 This 
allowed further scientific inquiry into medical, psychological and sociological forms 
of disability in order to form comprehensive rehabilitation care. This will be looked at 
further using the relevant conceptual frameworks that have been introduced by authors. 
 
There are some main classes of models used to describe disability, which include the 
biomedical, psychosocial, functional, and integrated models. Each model views 
disability from a different perspective to the other, hence adding a different outlook to 
disability.119 
1.2.3.1 Biomedical model 
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The initial understanding of disability arose from the biomedical model, which stated 
that disability was a direct consequence of a physical disorder, injury or disease. This 
model assumes that disability can be improved, cured  or progression could be halted 
using appropriate management options.119 
1.2.3.2 Psychosocial models 
A psychological model indicates that those with a disability execute tasks because they 
are influenced by the same psychological processes as those without a disability. While 
a social model of disability demonstrates that an individual cannot partake in activities 
not only as a result of their disability but also because of social barriers, negative 
attitudes of those without a disability and environmental constraints. The social model 
emphasises that better access to facilities should be provided for those with disability. 
The removal of social barriers and constraints with a view to improving the disability 
status, may make it difficult to implement this model in practice. The concept behind 
this model has proven difficult to understand by healthcare professionals and it 
neglects to grasp the complexity of diseases.119, 120 
1.2.3.3 Functional models 
A functional model of disability is based on the external expression of the disease or 
the impairment. Thus, this model requires adaptation of any treatment provided to 
improve the patient function rather than to treat the underlying disease. Often those 
who have considerable functional limitations are classified as being disabled, while 
those without considerable functional limitations are classified as physically fit. Thus 
disability under the functional model may be viewed as dichotomous. Functional 
models have the advantage of adopting a pragmatic approach to assess disability.  This 
model takes a large number and classifies them into smaller accommodating groups. 
This model carries the risk of being over simplistic as it turns a blind eye to the fact 
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that disability occurs on a continuum and in addition has the influence of physical 
factors and other external factors such as environmental factors.119 
1.2.3.4 Integrated models 
Most of the literature available on the conceptual frameworks defining disability has 
integrated two or more models from the existing conceptual frameworks.119 These 
models have proven to have more success when describing disability.  
1.2.4 Major disability models  
 
An article in 2003 by Jette and Keysor121 proposed  three major disability models used 
in practice and research. These include the ‘Disablement Model’ which was developed 
from the theory proposed by Nagi122, the WHO’s International Classification of 
Impairments, Disabilities and Handicaps (ICIDH)123 and its revision, the International 
Classification of Functioning, Disability and Health (ICF).124 All these three models 
share a common view that disablement signifies a series of related concepts that 
describes the health impact or consequences of a disease. The ICF is superior to the 
other two models as it portrays the disability framework well.121  
1.2.4.1 International Classification of Functioning, Disability and Health 
 
The WHO echoed the shift in models from disability to function by revising the 
existing ICIDH -1980 to the updated International Classification of Functioning, 
Disability and Health- 2001 (ICF)124 as it was believed to need a more comprehensive 
bio-psycho-social model to assess function. 
This ICF model views disability and functioning as outcomes of the interactions 
between health conditions and contextual factors. The latter consist of personal and 
environmental factors. The ICF identifies different components that interplay between 
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person, their ability and the environment. These components can be used in a 
description on how disability has an effect on one’s disablement process. The 
production of such an integrative model is vital to the multidisciplinary management 
of disability. 
The ICF identifies three components of human functioning: (1) impairments to body 
structures and functions; (2) activity limitations; and (3) participation restrictions, each 
of which is affected by personal and environmental factors.  
Definitions for each of these components were described by the ICF. Impairments are 
described as “difficulties and/ or deviations from body functions or structures,” activity 
limitations are defined as “difficulties an individual may have in executing tasks,” and 
participation  restrictions as “difficulties one may experience when engaging in life 
situations”124.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Activity 
Body Structure 
and Function 
 
Heath condition 
(Disease/ Disorder) 
 
Participation 
Personal 
Factors 
Environmental 
Factors 
Contextual Factors 
Figure 3 Components of the ICF classification system100 
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The ICF does not clearly distinguish ‘activities’ and ‘participation’ as separate 
domains. The literature on this matter acknowledge that users may wish to differentiate 
the terms, hence supplying the user with definitions and possible ways of using the  
respective domains activities and participation.124  
This model has incorporated the biomedical model, psychological model and the social 
model to produce the ‘biopsychosocial’ view on disability.  
Since its introduction, the ICF model has been widely established in professions as an 
organisational model of disability and as a classification platform for assessment, 
measurement tools and analysis and management of data.119 The advantage of the ICF 
is that it provides an international language through its framework and coding systems 
thus allowing interpretation of data related to disability much easier. This model does 
come with the disadvantages such as the inability to identify causes of disability, 
ignores the contribution of QoL in its framework and inadequate weighting on personal 
and environmental factors that potentially have an impact on disability caused by 
disease. Yet the ICF is able to portray the dynamic course of function and disability 
and remains one of the best available conceptual frameworks to enable the 
understanding of the complex process caused by disability.119  
1.2.5 Measurement of disability/ function 
The limitation in function once acquired becomes one of many defining characteristics 
of the individual.116 It has been highlighted in the literature that an accurate 
representation of function as such cannot be obtained from medical records.125 In 
addition the need for functional health measures has been highlighted in the literature 
several times.126 Impairment of function has been recognised to be an outcome of 
disease, but physiotherapists and those involved in rehabilitation may consider this a 
diagnosis, as their goal is to improve function.  
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Activities of Daily Living (ADL) are the standardised method of assessing 
disability.127 ADL predominantly consist of self-care which is needed fundamentally 
for functioning; whereas instrumental activities of daily living are activities that allows 
for both fundamental and independent functioning.128 These instrumental activities of 
daily living are what one would carry out as a representation of the population as a 
whole and therefore carry the fault of ecological fallacy. Results obtained from meta-
analysis shows that there is a high correlation between the severity of impairment and 
ability to perform ADL. Severe impairment is not strongly correlated to QoL.129 
Assessment of function enables professionals to gain insight into the patients’ 
disability.130 It provides invaluable information regarding the effectiveness and the 
quality of care provided to the patient and the outcome. 
1.2.5.1 Outcome measurement  
There are two methods in which functional capacity can be assessed. They are self-
reported measures (patient reported outcome measures) and performance based tasks. 
In addition to function, disability can be assessed by evaluating the degree of joint 
destruction utilising physical scores or imaging scores. 
1.2.5.1.1 Patient Reported Outcome Measures 
1.2.5.1.1.1 Overview 
Historically, the quality of medical care was assessed using measurement tools that 
had been developed by researchers. These instruments were based on medical models 
that in most instances were only understood and appropriately interpreted by 
healthcare professionals themselves. This method of evaluation led to the loss of 
crucial information about treatment effects experienced by the patients.131 Since the 
advent of Patient Reported Outcome Measures (PROMs), the paradigm shifted to 
provide equal priority to the patients’ views rather than focussing solely on 
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pathophysiological measurements. As patients remain the better judges of their 
impairment, they have a central role in managing their disease and provide feedback 
with regards to the quality of medical care received. This patient centred approach 
remains a fundamental component of patient care.132 PROMs are defined as “a 
measurement based on a report that comes directly from the patient about the status of 
a patient’s condition without amendment or interpretation of the patient’s response by 
a clinician or anyone else”131, 133. 
Patient perspective and experience as obtained from a PROM are important factors 
affecting the decision-making process when monitoring the effectiveness of a 
treatment. PROMs provide a unique perspective into the observable concepts whilst 
enabling measurement of non-observable concepts. 
PROMs are used in the standards of quality improvements while encouraging decision 
making with regards to patient care. It has the additional benefit of enabling patients 
to voice their opinion and interpret health status leading to higher accountability, 
greater patient satisfaction and autonomy when compared to other proxy measures.134   
1.2.5.1.1.2 History 
PROMs were developed for use in the National Health Service (NHS), and endorsed 
by the UK government department of health.135 Initially developed for research 
purposes, PROMs facilitated comparison between the quality and performance offered 
by healthcare providers for resource allocation.136 The use of PROMs in research is 
believed to be the only evidence-based tool available to doctors in obtaining a patient’s 
perspective on disease management.132 Since its mandatory introduction in elective 
procedures nationwide in the NHS in 2009, an improvement in the doctor-patient 
relationship, a significant change in the delivery of healthcare, disease diagnosis and 
monitoring have been observed.137, 138, 139, 140 This has led to PROMs being well-
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established in routine practice especially in providing regulated patient focussed 
management by a range of healthcare professionals including clinicians as well as 
physiotherapists.134 
1.2.5.1.1.3 Typology 
PROMs constitute a family of instruments that have the ability to measure a variety of 
features. Valderas and Alonso141 identified three main classifications that were 
consistent in the PROM literature,  
• Construct (objective of the measurement) 
 Example:  
 Symptoms  
 Functional status  
 Health perception  
 Health related quality of life  
 Other  
• Population assessed  
Examples:  
 Age,  
 Gender,  
 Disease specific versus generic  
 Culture  
• Measurement model implemented 
 Examples:  
 Metrics [psychometrics, econometrics, clinimetrics, other] 
 Dimensionality [index, profile, index and profile]  
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 Adaptability [completely standardised, partially individualised, 
completely individualised].141  
In addition PROMs have been classified according to the objective of assessment: 
descriptive, evaluative and predictive.142  
1.2.5.1.2 Performance measures 
As the name suggests performance measures require the patient to perform certain 
tasks, usually in the clinic, which are objectively scored by an independent observer, 
who is often a healthcare professional.143 These measures have been produced to 
address the recall bias associated with PROMs.144 These instruments like any other, 
evaluate function by using predetermined criteria that has been validated. There are 
various types of performance measures. Some assess the ability to execute a task, while 
others subjectively assess the level of difficulty required to perform a task. Another 
performance measure of physical function assesses the time needed to perform a task. 
In addition to physical functioning, cognitive function and visual functioning can be 
assessed this way.  
 
1.3 Definitions of concepts  
 
1.3.1 Theories of methodology  
Conceptual frameworks 
Conceptual frameworks are based on basic scientific principles and models and guide 
terminology measurement and hypothesis. These form the foundation on which 
research and clinical care are built.114  
Psychometrics  
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Psychometrics focus on the psychological aspects involved in the development of an 
instrument. Two main theories exist within this category namely the classical test 
theory and item response theory.145-147 
Clinimetrics 
This principle was introduced by Feinstein who defined it as the 'measurement of 
clinical phenomena' of an instrument. This view clashed with the psychometric view 
as its aim was to endorse clinical expertise to develop the measurement instruments.148    
Novel approaches avoid specification of such psychometric or clinimetric 
terminology.149 As such measurement properties should be assessed using the most 
adequate methods, models without specifications of a particular methodological theory 
are preferred. 
 
1.3.2 Measurement models 
Measurement models depict the causal relationships between the construct measured 
and its items. There are two main measurement models, reflective model and formative 
model.  
• Reflective model 
In a reflective model the construct manifests itself in the items. The construct is treated 
as a latent variable in addition to its error while the items are treated as effect 
indicators. A reflective model can be based on the classical test theory, reliability 
estimation and factor analysis. An example of a reflective model would be the 
construct ‘depression’. Here a person’s level of depression can be evaluated using 
variables such as low mood, anhedonia, and fatigue. As the construct ‘depression’ 
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increases, so will the indicators. Therefore as items manifest itself in the construct 
these items are expected to correlate.150, 151 
• Formative model 
In a formative model the items form the construct. The theory that supports this model 
defines the construct as a composite variable, which is summarised by the causal 
indicators, the items. Incorporating the same example as above where ‘depression’ is 
the construct the following items could be used as causal indicators. These include, 
loss of a close relation, chronic disability or disease and loss of a job. Here each 
indicator will have an input to the construct and as each indicator alters so will the 
construct. As items do not share a common theme they do not necessarily correlate 
with each other.150, 151  
The relationship between the items and the constructs are depicted in figure 3.   
 
 
 
 
 
  
 
 
 
 
 
Coltman et al150 compared both measurement models under the theoretical and 
practical domains.150 Even though this study was primarily based on the business 
Construct 
(Composite 
variable) 
X1 
X2 
X3 
X4 
Construct 
(Latent 
variable)  
Y1 
Y2 
Y3 
Y4 
Effect indicators 
Reflective model Formative model 
Figure 4 Reflective model versus Formative model 
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literature, it can be applied to the medical context. Table 1 summarises these 
differences. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1 Reflective versus Formative measurement models126 
  Reflective model Formative model 
Theoretical 
differences 
Construct Construct exists independent 
of the indicators  
Construct is determined as a 
combination of its indicators 
Causality Causality occurs from the 
construct to items 
Causality  occurs from items 
to construct 
Items Items manifests themselves 
in the construct therefore 
share a common theme, items 
are interchangeable, addition 
or removal of items do not 
change the conceptual 
framework of the construct. 
Items define the construct, 
items not necessarily share a 
common theme, items are not 
interchangeable, addition or 
removal of an items will 
change the conceptual 
framework of the construct. 
Practical 
differences 
Inter-correlation Items should have high 
internal consistency and 
reliability 
Items can have high or low 
internal consistency  and 
reliability but should have the 
same directional relationship 
Item 
relationships 
Items have a significant 
relationship with those that 
precede the construct or those 
that follow the construct 
Items may not have a 
significant relationship with 
those that precede the 
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construct or those that follow 
the construct 
Measurement 
error and 
collinearity  
Measurement error exists for 
each item and can be 
identified 
Measurement error is not 
applicable per item but is 
applicable for the construct as 
a whole.  Collinearity should 
be excluded. 
 
 
1.3.3 COSMIN 
COnsensus-based Standards for the selection of health Measurement INstruments 
(COSMIN) produced a critical appraisal checklist, (the COSMIN checklist) to evaluate 
the methodological quality of the measurement properties in a PROM.152 This 
checklist was part of a larger study, the COSMIN initiative, that produced definitions, 
structure, and methods in the evaluation of health related patient reported outcomes. 
The COSMIN study was principally a Delphic study where a consensus was reached 
for the inclusions, definitions and assessment of measurement properties.153 The 
definitions of measurement properties were produced as a part of the COSMIN 
taxonomy.152, 153  
 
1.3.4 Measurement properties  
As the scores obtained from PROMs are implemented in the decision making, 
investigations and management, the measures should be reliable and valid. Any 
failures in these would lead to imprecise assessment and biased decisions resulting in 
incongruous conclusions. As PROMs measure unobservable constructs it is vital that 
such tools contain adequate measurement properties as the consequences would be 
unfavourable.152 
Measurement properties assess the qualitative nature of the measurement tool.153 The 
definitions from the COSMIN taxonomy study153 were selected as the foundation for 
providing definitions for terminology of the measurement properties.  
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The COSMIN taxonomy defined three quality domains that contained these 
measurement properties. The authors further went on to describe aspects of certain 
measurement properties.  
 
The first domain, reliability was defined as the extent to which the measurement is 
absent from measurement error.153 Here the extent to which scores for patients who 
have not changed should be the same for repeated measurements under several 
conditions. Definitions for the measurement properties under the reliability domain 
were as follows;  
 Internal consistency was defined as the extent to which the items are interrelated.153  
 Reliability was described as the proportion of the total variance in the measurement 
caused by changes in the consistency of the scores.153  
 Measurement error was defined as error that is not attributed to true changes in the 
construct assessed but instead caused by the systematic and random error of a 
patient’s score.153 
 
The second domain, validity was defined as the extent to which a PROM relates to the 
construct it is expected to measure.153 Definitions of the measurement properties of the 
validity domain are shown below;  
 Content validity was defined as the ability to reflect the construct being measured 
in the PROM’s content.153 Face validity was described as an aspect of content 
validity.  
- Face validity was defined as the extent to which the items of a PROM 
represents the construct being measured.153  
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 Construct validity was described based on the assumption that the PROM validly 
measures the construct meant to be measured, it is the extent to which the scores of 
the PROM are consistent with the hypotheses.153 Three aspects of construct validity 
were separately defined, structural validity, cross cultural validity and hypothesis 
testing.  
- Structural validity was defined as the extent to which the dimensionality of 
the construct being measured is reflected by the scores of the PROM.153 
- Cross-cultural validity was described as the ability of items to mirror the 
performance of the translated or culturally adapted PROM to the original 
PROM.153 
- Hypothesis testing was described as the characteristic assessing construct 
validity which takes the form of a hypothesis test.153 
 Criterion validity was defined as the extent to which a score of a PROM reflects the 
score of its ‘gold standard’.153 
 
The third domain responsiveness stands alone as it consists of the measurement 
property ‘responsiveness’. In both instances responsiveness was defined as “the ability 
of a PROM to detect change over time in the construct to be measured”153. 
The exact definitions used in the COSMIN taxonomy are available in Appendix 1.   
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Figure 5 COSMIN taxonomy129 
 
1.3.5 Other properties 
These properties have not been the focus of a vast majority of the literature which 
could possibly be due to its straightforwardness or to the fact that it is actually 
overlooked by most and is taken for granted.  
Interpretability, was defined in the COSMIN taxonomy even though it was not 
classified as a measurement property. Fitzpatrick et al154 highlighted acceptability, 
feasibility and precision as essential practical properties that should be possessed by a 
PROM.154 Ever since, these properties have been cropping up in the literature.  
The International Society for Quality Of Life research (ISOQOL) 155  recommended a 
minimum requirement checklist for the evaluation of measurement properties of a 
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PROM. Those not covered among the measurement properties in the COSMIN include 
conceptual and measurement models and burden. 
Upon definition of each property it becomes evident that there is no consensus among 
these terms and frequent overlap in the definitions occur (e.g. burden and acceptability, 
burden and feasibility). This is in contrast to the measurement properties, which is 
probably due to the lack of a study similar to the COSMIN on the other properties. 
 
Interpretability, is the extent to which a person can accredit qualitative meaning to 
the score of a PROM. 153   
Acceptability, is the willingness or ability of patients from the target population to 
complete the questionnaire.154  
Precision  as described by Fitzpatrick et al154 indicates how precise the scores of the 
instrument are and its ability to make distinctions made by an instrument. Previous 
authors noted that this aspect has also been known as sensitivity.156  
Feasibility, this assesses the burden on the healthcare professional. It considers the 
time and cost of administration, speed and ease of scoring and feedback of information 
and interpretation for clinicians, researchers and other staff.154  
Conceptual and measurement model155 
Conceptual model- Provides a framework that describes the desired construct to be 
included in a PROM.  
The measurement model- Outlines the individual items in the PROM to the construct 
to depict its relationship to each other. 
Responder and administrator burden-This was defined by the ISOQOL study as  
the time, effort, and other demands placed on those to whom the instrument is 
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administered (responder) or on those who administer the instrument (investigator or 
administrator).157 Such factors include the questionnaire length, time constraints when 
filling in the questionnaire and the need for physical help when filling in the 
questionnaire.131 Other ways to minimise burden include ensuring that the 
questionnaire is written in a way that can be comprehended by a 12 year old.158 To 
assess the reading ease of a questionnaire in English, Flesch-Kincaid readability tests 
have been produced.159 This includes the Flesch reading ease score which assesses the 
word length and the sentence length. The Flesch-Kincaid grade level translates the 
reading ease score into a grade level of the United States. The results are able to 
provide a reading age range for the questionnaire.159 Patient burden closely ties in with 
acceptability of the questionnaire as described by Fitzpatrick et al.154 Part of 
investigator burden is the ease of access. The requirements of copyrights and 
associated cost issues will all play a role in the actual practical process of obtaining a 
PROM.   
 
1.4 Outcome measures in haemophilia  
 
There are a variety of outcome measures used in haemophilia for both the paediatric 
and adult populations. Some of those have been solely produced for haemophilia 
(disease specific) whereas others were produced as generic scores for other diseases 
but have been used and/or validated in haemophilia.  
Scores to measure outcomes have been developed in various categories and include, 
physical examination scores, imaging scores, functional scores, QoL measurement, 
mortality, bleeding frequency and cost utility measures. Boehlen et al29 carried out a 
systematic review in 2014 to identify all the outcome measures used amongst 
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hemophiliacs over a period of ten years. This study was used as a guide to summarise 
the existing scores under the categories of physical scores, imaging scores and QoL 
measures.  
1.4.1 Physical examination tools 
Boehlen et al29 identified two chief physical scores, the WFH Physical Examination 
score (also known as the Gilbert score)160 and the Haemophilia Joint Health Score 
(HJHS)161 . 
The Gilbert Score160 results in joint specific scores as well as an overall score. This 
questionnaire is available in English, Swedish and Dutch and takes about 30-45 
minutes to complete. This clinician-administered measure does not require special 
equipment apart from a goniometer and a tape measure but does require administrator 
training. The Gilbert score has been tested on samples of children, but a full validation 
process, assessing its measurement properties such as reliability and responsiveness 
has not been done. This score is well adapted for the use where there is limited access 
to prophylaxis and factor replacement that comes with the drawback of being 
somewhat insensitive to mild joint disease.29, 160  
The most up to date version of the HJHS provides joint specific scores, global gait 
scores and a total score. It is available in English, Dutch, Swedish and Mandarin and 
requires no special equipment. Administration of the HJHS by a clinician can take 45-
60 minutes and the administrator needs to be adequately trained. This is predominantly 
designed for children with haemophilia aged 4-18 years and interpretation of values 
should be made according to the reference value for each age group.162 The HJHS is 
more sensitive than the Gilbert score and is able to detect early signs of joint damage, 
hence proving useful in the monitoring of those on prophylaxis. The first version was 
tested and validated in children but has not been studied in adults or those with severe 
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disease.163 The HJHS carries excellent reliability, correlates well with WFH score and 
correlates highly with radiographic features of destruction.29, 164, 165 
1.4.2 Imaging scores 
Another form of clinician reported assessment is radiological imaging scores. These 
enable deduction of the degree of joint destruction in haemophilic arthropathy in 
addition to being a mode of investigation of assessing complications. The common 
evaluative techniques identified in Boehlen et al29 are X-ray, ultrasound and Magnetic 
Resonant Imaging (MRI). 
The oldest method used to assess joint damage in haemophilia is X-ray which still 
remains a useful method of monitoring progressive joint disease but it is unable to 
detect early changes. The two chief scores implemented in practice are the Arnold-
Hilgartner system67 and the Pettersson scale 166, 167. The Arnold-Hilgartner system is a 
progressive score that is simple and is more user friendly while the Pettersson score is 
an additive score thus more difficult. Both of these scores have good intra-observer 
reliability and inter-observer reliability.168 Conventional radiology, has the 
disadvantage of being unable to detect osteochondral pathology in early disease. 
Ultrasound allows examination of both soft tissues as well as cartilage surfaces acts. It 
is easily accessible but it is operator dependent. Ultrasound can be utilized to detect 
early arthropathy and has used as a diagnostic tool.169 There have been scores 
undergoing development that look into standardising these scores.170,171 The 
ultrasound scores have been known to correlate well with the bleeding episodes.172 
There are two established MRI scores in today’s practice, the Denver MRI score173 
and the European MRI score174. The European score gives better evaluation of soft 
tissue and osteochondral changes but comes with the disadvantage of being more 
complex.174 There have been many more MRI scoring systems used in the literature 
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making it difficult to compare results across cohorts. The International Prophylaxis 
Study Group (IPSG) have aimed to bridge this gap by standardizing MRI 
interpretation.175 Their score is a combination of a progressive and additive scale, 
which is highly reliable and has a low correlation with clinical parameters but does not 
allow discrimination between the severities of haemophilia.174-177  
MRI is advantageous compared to other methods, as it allows better visualisation of 
soft tissue and cartilage changes, and being free of ionising radiation. MRI is the gold 
standard to detect early joint changes, staging and follow-up. MRI as a whole is shown 
to have good reliability.178, 179 Drawbacks associated with MRI are that it is expensive, 
not easily accessible and requires sedation in young children. 
In addition to the above imaging techniques computer tomography, scintigraphy and 
positive emission tomography have been used in haemophilic arthropathy but have 
proven to be of limited use in the follow up of the disease. Imaging scores although 
accurate in detecting subtle changes, are not reflective of disability.  
1.4.3 Quality of Life measures 
The subjective and personal nature of QoL was described in the WHO definition of 
QoL as “an individual’s perceptions of their position in life in the context of the culture 
and value systems in which they live and in relation to their goals, expectations, 
standards and concerns”180.  Researchers have later gone on to develop the term Health 
Related Quality of Life (HR-QoL) which is defined as the impact of health on QoL as 
it is accepted that medical systems are unable to address all concerns inclusive in 
QoL.181  
HR-QoL has become an important part of the way clinicians assess the outcome of 
disease. In general, HR-QoL instruments measure more relevant health outcomes such 
as physical, mental and social wellbeing as it is a complex multi-domain construct.132 
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There have been many generic questionnaires produced to measure a patient’s HR-
QoL. Not many have been produced in the English language that are validated to be 
used in haemophilia. 
As highlighted by Boehlen et al29 majority of the QoL measures specific to the 
haemophilia population are difficult to implement in the English speaking community. 
This is due to the fact that there is insufficient evidence on the translations and cultural 
validation. The Hemofilia-Qol182 was developed in Spain and is only validated in 
Spanish. The Qual-Hemo183 was developed in France and caters to a wide range of age 
groups and to date there appears to be no validated translation in English available. 
The Qual-Hemo does show sufficient convergent validity with a subscale of Short 
Form-36 (SF-36) questionnaire. The Haemolatin-QoL184 questionnaire developed by 
a Latin-American group is available in Spanish and Portuguese but unavailable in 
English. 
The Haem-A-QoL185 was originally developed in Italy and consists of 46 items 
compiled from focus groups of patients with haemophilia in different countries. Here 
the Cronbach’s alpha ranged from 0.74-0.88 and there was high convergent validity 
with the SF-36 questionnaire. The Haem-A-QoL is validated in Germany, Hungary 
and the UK and linguistically validated into 17 languages. It consists of good 
measurement properties particularly, reliability, convergent validity and discriminant 
validity.185  
Haemo-QoL-A was developed and validated in 2008 by Rentz et al186 in a multicentre-
multinational study. This is the adult form of the Haemo-QoL questionnaire. Item 
generation was based on a literature search, and clinical input from patient and 
healthcare professional focus groups in North America and Europe. Cross-cultural and 
linguistic validation took place across 4 cultures and 3 languages. This PROM consists 
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of 6 subscales which are; physical functioning, role functioning, consequences of 
bleeding, worry, emotional impact, and treatment concerns. There are a total of 41 
questions to assess the patients HR-QoL. It has good internal consistency and in 
addition correlates well with the SF-36.186  
For the paediatric population the Haemo-QoL and the Children Haemophilia Outcome 
(CHO)-Kids Assessment Tool (KLAT) questionnaires exist. The Haemo-QoL is 
available in its original form187 and also in a shorter version which is known as the 
Haemo-QoL index188. This questionnaire is available in English, French, Italian, 
German, Dutch and Spanish. Initial studies showed satisfactory reliability and validity 
testing.187 Subsequently the questionnaire was validated in 6 other countries which 
showed acceptable results in reliability and construct validity.189 The CHO-KLAT190 
was produced by a Canadian group and is available for three age groups.  
A systematic review carried out by Szende et al191 in  2003 aimed to identify HR-QoL 
instruments used among adult persons with haemophilia. The assessment of the results 
identified that the SF-36, SF-12, EuroQol-5D, health utilities index, and arthritis 
impact measurement scale-2 were the main general- non-specific instruments used. 
 
1.5 Hypothesis 
 
The hypothesis for this study is that the existing functional scores in the adult 
persons with haemophilia are suboptimal in their developmental methodologies and 
that they are inadequate in its measurement and other properties. 
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1.6 Aim 
 
The aim of this study was to carry out a systematic review of all the available disease 
specific functional measurement instruments used in the adult English speaking 
haemophiliac population.  
  
43 
 
2 CHAPTER 2- Methods 
 
 
 
2.1 Literature search 
 
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
guidance for systematic reviews was followed throughout this study.   
Multiple databases, PubMed and Scopus databases were searched using certain 
Medical Subject Heading (MeSH) terms and were combined with Boolean terms to 
expand the search.  These search terms were included in such a way that it could be 
expanded ensuring inclusion of relevant synonyms, alternative spellings and related 
terms. Backward referencing of eligible articles were carried out to include an 
increased number of relevant studies. 
The search was not limited to a specific year range, in order to enable inclusion of a 
wide array of articles.  
All searches carried out in both search engines were limited to human studies that are 
in English. The literature search was last carried out on the 2nd of August 2016. 
MeSH terms used are shown in table 2. A MeSH term from column 1 was used in 
combination with column 2 and column 3 using the Boolean term ‘AND’.  
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          Table 2 MeSH terms used 
MeSH 1  MeSH 2  MeSH 3  
Haemophilia Function Score  
Hemophilia  Assessment 
  Measure 
  Outcome 
 
It was ensured that all mentioned instruments were developed for haemophilia (disease 
specific), assessed the construct function in adults and assessed overall joint function 
as opposed to just the function of a single joint. The severity of haemophilia are those 
with moderate to severe haemophilia as this is the group that have spontaneous 
haemarthrosis.  
2.1.1 Inclusion criteria  
1. Adult persons with haemophilia   
2. Instruments developed for persons with haemophilia (disease specific 
instruments)  
3. Instruments that assess the construct ‘function’. 
4. Data on PROMs or performance based assessments.   
2.1.2 Exclusion criteria   
1. Studies that assess the physical examination scores or imaging scores 
2. Joint specific scores 
This is further clarified in table 3 below, which explains the rationale for inclusion 
and exclusion.  
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 Table 3 Inclusion and exclusion criteria 
 Description Rationale 
Inclusion 
Criteria 
Adult persons with 
haemophilia 
The adult population has a variety of 
comorbidities affecting function with varying 
degrees of joint disease. Which is separate 
from the paediatric population who have 
access to prophylactic factor concentrates and 
less comorbidities. Type of haemophilia of 
interest are the congenital forms ( haemophilia 
A and B). 
Disease (haemophilia) 
specific instruments  
Generic instruments contain items that are 
irrelevant to the target population which 
comes at the expense of the length of the 
instrument.  
Instruments that assess 
the construct ‘function’   
As per research question. 
Data on PROMs or 
performance based 
assessments.   
Types of measurement instruments that assess 
the construct ‘function’   
Exclusion 
Criteria 
Studies that assess the 
physical examination 
scores  
 
Even though physical examination may seem 
similar to assessment of function, these two do 
not assess the same construct. A good physical 
examination score does not necessarily mean 
or indicate how well a patient is able to 
function. 
Joint specific scores As haemophilia is a systemic disease it tends 
to affect more than one joint. Therefore a 
questionnaire should focus on function of all 
limbs. 
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2.2 Evaluation 
 
Studies that were analysed were those that looked at function, joint procedures, and 
outcomes in persons with haemophilia. The eligible studies were searched for a 
mention of a functional score, this functional score was later individually searched to 
ensure eligibility.  
Once the instruments were identified from the literature, each instrument was searched 
on an individual basis on the PubMed and Scopus databases to identify all relevant 
articles produced containing that instrument. This search was carried out to ensure that 
no article containing vital information regarding the piloting or validation of the 
instrument was lost. This search had no year restriction although it was restricted to 
human studies available in the English language.  
The articles that provided information on the pilot study and/ or validation study were 
located to extract data and summarise instrument characteristics. Subsequent studies 
that assessed properties which were not assessed in the initial validation were included. 
Where an initial pilot study was carried out in those with larger validation studies, data 
from the pilot study was included only where the validation study did not assess all 
properties. Access to questionnaires was of paramount importance, where open access 
to the questionnaires were not available this was obtained by contacting the authors. It 
was ensured that the article was produced in the English language and that the 
instrument had a version in English. Where full measurement properties in the English 
version were unavailable the original version was evaluated whilst summarising the 
results of the English instrument. Each study and questionnaire was evaluated for its 
development methodology, measurement properties as assessed by the COSMIN 
checklist and certain other properties which will be described below.   
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2.2.1 Development of instruments 
The methodology utilised in the development of instruments is often neglected in the 
literature. This stage plays a vital role in the quality of items included in the instrument. 
Methods of development are variable depending on the discipline and is subjected to 
the judgement of the developers. The basic aim is to generate items which could be 
tested in subsequent pilot and validation studies.149 This systematic review summarises 
the methods in which each instrument was developed. This included giving particular 
attention to the groups of participants used for item generation.  
2.2.2 Measurement Properties 
Measurement properties were evaluated using the COSMIN 4-point checklist. As 
introduced previously, the COSMIN checklist covers standards for the defined 
properties of health measurement instruments in terms of its design and statistical 
methods.192 The content of the checklist with 4-point rating scale consists of twelve 
sections out of which ten sections are used to assess the methodological quality.  Here 
the measurement properties as defined by the COSMIN taxonomy; internal 
consistency, reliability, measurement error, content validity, structural validity, 
hypothesis testing, cross cultural validity, criterion validity and responsiveness are 
assessed. The 4-point rating scale enables to calculate an overall methodological 
quality score for each measurement property which can take a value of excellent, good, 
fair or poor. Under each measurement property there is a variety of criteria that are 
rated on the 4-point rating scale. Each measurement property is scored by employing 
the lowest score in the criteria under the measurement property in the study. In addition 
to the defined measurement properties assessment of interpretability of the instrument 
is available in the checklist.192 It should be noted that this is not given a quality score. 
Evaluation of overall characteristics include general requirements under the categories 
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of generalisability and item response theory methods.192 Prior to evaluation of each 
questionnaire, the author read the COSMIN checklist manual which is available on the 
COSMIN website.193 The author of this study evaluated the measurement properties 
against the COSMIN 4-point checklist and where there were uncertainties discussions 
were held with two statisticians in the department.  
2.2.3 Other properties  
Data extraction for interpretability (table 4) is supported through the COSMIN 
checklist. In addition, as the COSMIN checklist provides a generalisability data 
extraction box, this information was extracted. Thus these properties were summarised 
using the COSMIN checklist as a template.  
As there is an overlap between acceptability and patient burden, and feasibility and 
investigator burden, the properties acceptability and feasibility will be assessed within 
the property burden. Precision of an instrument was assessed by analysing the 
categories and the number of items on the response scale. 
 A conceptual model of each instrument as described by the respective authors are 
summarised. Here, the approach used by each author to describe the construct 
‘function’ was explored. A measurement model where mentioned would be stated as 
a formative or reflective model. Where this is ambiguous a ‘thought test’ is carried out 
to depict the direction of change of items when the construct changes. When carrying 
out the ‘thought test’ if items change when the construct changes it is suggestive of a 
reflective model whereas if a change in the items caused a change in the construct it 
was a formative model.193  
Burden consists of patient and investigator burden. Patient burden was assessed by the 
time required for completion, instrument length, response rate ( as well as assessing 
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acceptability) and readability. Readability was assessed by calculating the Flesch 
reading ease score and the Flesch-Kincaid reading grade level for each instrument. 
(table 5) It should be noted that the readability was applicable for the English versions 
of all of the instruments to allow for uniformity in analysis. Investigator burden 
(feasibility) was assessed by the ease of access to the instrument, and training required 
to implement the instrument in practice.  
Where additional properties are evaluated in each instrument, this will be summarised 
as ‘other properties reported’, even though no such evaluation of the properties will be 
made.  
 
 
Table 4 Data extraction for interpretability 
Interpretability 
 Percentage of missing items  
 Description on how missing items were handled 
 Distribution of the total scores  
 Percentage of the respondents who had the highest possible total score 
 Scores and change in score (i.e. means and Standard deviations) for relevant (sub) 
groups 
 Minimal Important Change or Minimal Important Clinical Difference 
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Table 5 Interpretation of readability scores 
Flesch reading 
ease score 
Flesch-Kincaid 
reading grade 
Description 
90.0-100.0 5th  Very easy 
80.0-90.0 6th Easy  
70.0-80.0 7th Fairy easy 
60.0-70.0 8th-9th Standard 
50.0-60.0 10th-12th  Fairly difficult 
30.0-50.0 College Difficult 
0.0-30.0 College graduate Very difficult 
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3 CHAPTER 3- Results  
 
 
 
3.1 Literature search 
 
The databases PubMed and Scopus were used for the literature search, whereby 3752 
and 1581 articles were obtained respectively. No articles were identified through 
backward referencing. Duplicates were identified and excluded which resulted in a 
balance of 2096 articles. Titles of articles were read and 1872 articles were excluded 
as they did not meet the inclusion criteria. Out of those 194 articles were excluded 
based on reading either the abstract or full article. 
The process of the literature search and the results obtained are depicted in the flow 
diagram below (figure 5).  
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The search yielded a total of 30 studies that had the mentioned eligible instruments. 
Among the 30 studies there were three instruments mentioned. Namely the 
Haemophilia Activities List (HAL), the Functional Independence Score in 
Haemophilia (FISH) and the Haemophilia Exercise Project- Test- Questionnaire 
(HEP-Test-Q).  
 
Sc
re
e
n
in
g 
In
cl
u
d
ed
 
El
ig
ib
ili
ty
 
Id
en
ti
fi
ca
ti
o
n
 
PubMed 
search=3752 
Search limitations, 
• Articles of Human 
studies 
• Articles available in the 
English language 
 
Total 
5333 
2096 
Backward 
referencing= 0 
Exclude articles 
based on titles  
1872 
 
Eligible studies 
30 
Duplicates 
identified 3237 
Exclude articles 
based on 
abstracts and/ or 
full text 194 
 
Scopus  
search= 1581 
224 
Figure 6 Flow diagram of literature search 
53 
 
The distribution of the studies according to the scores mentioned are shown in table 6 
below.  
            
          Table 6 Instrument distribution in literature search 
Instrument mentioned Number of studies 
HAL  9 
FISH 7 
HEP-Test-Q 2 
HAL and FISH 10 
HAL and HEP-Test-Q 2 
Abbreviations: HAL – Haemophilia Activities List, FISH- 
Functional Independence Score in Haemophilia, HEP-Test-Q – 
Haemophilia Exercise Project Test Questionnaire 
 
 
The terms searched to identify all relevant articles per instrument were, “Haemophilia 
Activities List”, “Functional Independence Score in Haemophilia” and “HEP-Test-Q”. 
This search was last carried out on the 03 August 2016. The results of the individual 
searches are shown below.  
 
Table 7 Individual searches per instrument 
Instrument PubMed search Scopus search 
Haemophilia Activities List 17 23 
Functional Independence Score in Haemophilia 13 14 
HEP-Test-Q score 5 5 
 
The results identified that the principle scores used to assess function in adult persons 
with haemophilia are the HAL194, FISH195 and the HEP-Test-Q score196.  
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In addition to the results obtained, generic scores that are not disease specific to 
haemophilia were identified by the initial search. Those instruments used in the adult 
haemophiliac population to assess function are the Western Ontario McMaster 
Questionnaire (WOMAC)197, Stanford Health Assessment Questionnaire (HAQ)198, 
the Arthritis Impact Measurement Scale (AIMS)199 the Impact on Participation and 
Autonomy questionnaire (IPA)200, and the Canadian Occupational Performance 
Measure (COPM)201.  
As the information regarding the development, and cross validation of the HAL 
questionnaire was unclear, the authors were contacted to obtain further information. In 
addition the authors of the HEP-Test-Q were contacted to obtain a copy of the 
questionnaire as it was unavailable in the public domain.  
 
3.2 Evaluation 
 
3.2.1 Haemophilia Activities List 
HAL produced by Van Genderen et al194 in 2004 is a PROM that evaluates a patient’s 
functional status under seven domains. It is assessed by enquiring about a patient’s 
ability to do the following tasks: 
1. Lying/sitting/kneeling/standing (8 items) 
2. Functions of the legs (9 items) 
3. Functions of the arms (4 items) 
4. Use of transportation (3 items) 
5. Self-care (5 items) 
6. Household tasks (6 items) 
7. Leisure activities and sports (7 items) 
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This detailed questionnaire comprises of a total of 42 questions and the patient’s 
answers are rated according to a 6 point Likert scale. This instrument was developed 
and validated in Dutch and is available in 9 other languages including English.194 The 
article is available in English and provides measurement properties for the Dutch 
instrument, but makes no reference to the English version. This was clarified by 
contacting the author. This systematic review evaluates the properties of the Dutch 
version of the HAL as properties of the English HAL have not been tested.  
The disadvantages of HAL as highlighted by previous authors include its lack of 
sensitivity to detect clinical changes and the fact that it is language dependent.29, 35 The 
HAL pilot study and validated studies consisted of a sample size of 50194 and 127202 
respectively. The English HAL is included in appendix 2. 
3.2.1.1 Development of the HAL 
The development of the HAL took place in outpatient clinics involving the 
participation of patients with haemophilia. Item generation took place by carrying out 
semi-structured interviews using the McMaster-Toronto Arthritis Patient Preference 
Disability Questionnaire (MACTAR) as an interview guide.194 The MACTAR is an 
open ended questionnaire to identify activities that are deemed to be difficult for the 
patients.203 The aim of each interview was to identify a maximum of 10 activities that 
the individual struggles with, subsequently ranking the top 5 activities.194 This process 
was carried out on 162 patients and was halted once item saturation was reached. In 
those who took part in item generation, the distribution of the severity of the disease 
was, 73% (n=118) for severe, 10% (n=16) for moderate and 17% (n=28) for mild 
disease.194 Majority of the participants had haemophilia A 86% (n=140), while 10% 
(n=16) had haemophilia B. In addition to those with haemophilia some participants 
had a disease status of Type B-Leyden disease (n=1), von Williebrand disease (n=4) 
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and factor VII deficiency (n=1).194 The items generated were classified according to 
the ICF classification system. Items included were those that could be classified as 
‘Activities’ in the ICF while those that were in the ‘Participation’ category were 
excluded. These items were transcribed into questions which included a response scale 
option on a Likert scale.194    
3.2.1.2 Measurement properties  
Internal consistency measured using Cronbach’s alpha was 0.97 for the overall HAL 
questionnaire. The Cronbach’s alpha ranged from 0.61-0.96 for the subscales of the 
HAL.202 The COSMIN 4-point checklist192 quality standard was ‘poor’ as the sample 
size contained less than five participants per number of items (item 6). The test-retest 
reliability was not assessed in the HAL score. As reliability was not assessed, the 
measurement error could not be evaluated.  
The content validity of the HAL score was measured by asking patients and physical 
therapists if each item should be included and to rate the clarity of each item. Patients 
received the Dutch version of the questionnaire whilst the physical therapists received 
the English version of the questionnaire.202 The HAL questionnaire proved to have 
good content validity evidenced by a score of 8.0 (±0.7) and 7.7 (±1.0) from patients 
and physical therapists respectively. This was rated on a ten point scale where 10 was 
very good and 1 was very bad.194 This analysis was only carried out in the initial pilot 
study of the questionnaire. The content validity assessment utilising the COSMIN 
checklist192 received a ‘good’ rating as it consisted of a moderate sample size (item 2) 
and as the purpose of the instrument was assumed (item 3).  
The property construct validity that met the COSMIN definition was measured by 
validating the HAL against the Dutch–Arthritis Impact Measurement Scale 2 (Dutch-
AIMS2)204 and the Impact on Participation and Autonomy (IPA)200. This was referred 
57 
 
to as convergent validity by the developers.202 The statistical test used to assess this 
variable was the Spearman rank order correlation coefficient. Construct validity with 
the HAL and the AIMS2sum (total score) and AIMS2phys scores (which asses the 
physical component of the scale) showed excellent results where correlations were 
0.81 and 0.83 respectively.202 The construct validity with the IPAsum score showed a 
good correlation (0.71). All these results were statistically significant (p < 0.001).202 
Structural validity which is an aspect of the measurement property construct validity, 
was rated ‘poor’ in the COSMIN checklist192 as it contained a sample size of less than 
five participants per item (item 4). Hypothesis testing which is part of the measurement 
property construct validity, was rated ‘good.’ This was because the percentage of 
missing items were not described (item 1), presumptions had to be made on how 
missing items were handled (item 2) and because there were a minimal number of 
hypotheses formed (item 4). 
The original HAL was developed in Dutch, using the WHO's ICF classification 
scheme.124 Translation of the Dutch items into English was made based on the 
available international versions of the ICF. Only the original HAL had undergone 
validation whereas the translated English version of the HAL had not undergone any 
formal translation or cross-cultural validation process. As the questionnaire that was 
evaluated was the Dutch version the cross cultural validation was not applicable to this 
version of the instrument. Since the HAL is a PROM there is no criterion validity 
assessment applicable to the instrument. Responsiveness to the change of the HAL 
was not assessed either at the pilot stage, at validation or any subsequent studies.  
3.2.1.3 Other properties reported 
 
The authors assessed what was described as ‘construct validity’ in HAL by calculating 
the variance extracted through explorative factor analysis. This defined the underlying 
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construct for the instrument.202 The results showed that 6 items accounted for the 
75.9% of the total variance. The three factors that were responsible for 50.6% of the 
total variance were the ‘upper extremity’, ‘basic lower extremity’ and ‘complex lower 
extremity’. This aspect assessed by the authors tie in with the assessment of 
dimensionality of the internal consistency assessment.150, 202  
The clarity and style of each question, paying close attention to the font size, number 
of items and sequence of domains were carefully assessed at the pilot study.194 The 
results of the style of the HAL questionnaire as reported in the pilot stage by patients 
(Dutch version) and physical therapists (English version) was 8.2 (±0.4) and 8.1(±0.8) 
respectively. This was rated on a ten point scale where 10 was very good and 1 was 
very bad.194  
The Spearman rank correlation coefficient for the relationships between three 
performance tests and the HAL questionnaire were calculated. The correlation 
between the button test (a performance based test that requires the patient to do up and 
undo the three top buttons apart from the top most button of a standard shirt) and 
domains of the HAL were not significant or had low correlations (r=0.39).202 The 
highest correlations between the HAL domains were 0.66 for the 50 metre walking 
test, 0.65 for the timed up and go test and 0.61 the figure 8 walking test. The domain 
which had the highest correlation for each of the (latter three) performance tests was, 
‘lying/sitting/kneeling/standing’. 202 
3.2.1.4 Other properties evaluated  
With the data provided only one item in the interpretability box of the checklist could 
be filled in. This item evaluated the distribution of the scores (42-252). Characteristics 
of the generalisability box are summarised in table 8. Assessment of the precision of 
the HAL specifies each activity and motion to be assessed and has 6 response options 
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based on the ability to perform a task. The conceptual model assessed by the HAL was 
to assess the functional health status. This was carried out by measuring the 'activities' 
category in the ICF definition of disability.124 The ‘thought test’ suggests that the 
measurement model incorporated is a reflective model. Patient burden is higher than 
the investigator burden. The HAL is said to take approximately 10 minutes of the 
patient’s time.202 It is well laid out. As this questionnaire consists of 12 pages of text, 
which includes a page of an example, and how to score, this may be off-putting from 
a patient’s perspective in practice. Response rate ranged from 87%- 93% for the 
HAL.202 The Flesch reading ease score for the HAL questionnaire was 67.2 which was 
‘standard’ and has a Flesch-Kincaid grade level of 7-8 graders.159 The HAL has 
minimal investigator burden, as it comes cost free for those who require it. The 
questionnaire is available via the WFH website thus giving access to the public 
domain. (http://www.wfh.org/en/page.aspx?pid=875). This instrument requires no 
additional training as it is a PROM. The HAL has been in practice for almost a decade 
indicating that it has been taken up well by healthcare professionals.  
3.2.2 Functional Independence Score in Haemophilia                                                                             
In 2005, Poonnoose et al195 produced the FISH score which is a performance based 
questionnaire to assess the functional capacity of patients with haemophilia. This 
instrument consists of 8 items and aims to assess ADL, under three categories of self-
care, transfer and locomotion. The items that the patients are tested on are outlined 
below: 
1. Eating and grooming 
2. Bathing 
3. Dressing 
4. Chair 
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5. Squatting 
6. Walking  
7. Stairs (12-14 steps) 
8. Running  
These items are scored on a 4-point Likert score according to the level of assistance 
required when executing these actions in the presence of a healthcare professional. 
This instrument was not developed to assess challenging activities, and does not assess 
activities such as education or employment. As this is a performance based assessment, 
it can be used in different languages, but this does not allow for inaccuracies in 
translation by the administrator. The pilot study and validation studies in which the 
FISH was studied consisted of severe disease with sample sizes of 35195 and 63205 
respectively. The FISH score is included in appendix 3. 
3.2.2.1 Development of the FISH 
Item generation stage involved the participation of patients as well as their relatives 
and therapists. Participants were asked to list activities that were affected by 
haemophilia. Generated items were classified according to the ICF classification 
system and only activities that could be assessed objectively or performed at an 
outpatient setting were included. Distribution and demographics of the participants in 
the development of FISH were not provided by the authors.195  
3.2.2.2 Measurement properties 
The validation study205 of FISH score reported an internal consistency as measured by 
the Cronbach’s alpha of 0.85. This received a ‘poor’ on the COSMIN checklist192 as 
factor analysis was not performed  to assess unidimensionality of the scale (item 5)  
and a Cronbach’s alpha value was not calculated for each subscale separately (item 7). 
Reliability as assessed by intraclass correlation coefficient (ICC) was 0.98.205 This 
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results in a ‘fair’ score for the reliability estimate as it is unclear how missing items 
were handled (item 2) and because of other methodological flaws in the study (item 
10). As the reliability estimate given was not clear if it was for inter-rater or intra-rater 
reliability. The same reasons (apart from item 10) results in a ‘fair’ level for the 
measurement error property. The authors did not assess the content validity of the 
FISH. Nevertheless, they state that the FISH has good face validity due to the 
methodology of questionnaire development. Item generation incorporated both 
patients’ and healthcare professionals’ views. Content validity assessed in the 
COSMIN checklist192 received a ‘poor’ rating as this aspect was not assessed (items 
1, 2).195 
The construct validity was assessed using the WFH score160 and the Pettersson 
score166. The correlation coefficients were -0.61, and -0.38 respectively. This meets 
the criteria for structural validity and was rated ‘poor’ as no exploratory or 
confirmatory factor analysis was performed (item 6). Hypothesis testing was rated 
‘fair’ as the hypothesis was not formulated but it was possible to deduce what was 
expected (item 4). The FISH is available in English and it is a performance-based 
assessment. There has been no cross cultural validation that has been carried out to 
evaluate its properties in different cultures other than the Indian culture. The authors 
of the FISH assessed criterion validity by using PROMs to assess function. This 
included the HAL202, HAQ198 and WOMAC197 scores which showed correlation 
coefficients of, -0.66, -0.75 and -0.66 respectively. The criterion validity was given a 
rating of ‘good’ as it had an adequate sample size (item 3) and as it was presumed that 
the criterion was considered an adequate gold standard (item 4).  
The responsiveness was assessed by evaluating the difference in those who underwent 
surgery to correct a fixed flexion deformity of the knee.205 A Wilcox signed ranked 
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test was carried out and the standardised responsiveness mean of -1.93 was achieved 
for the FISH although the clinical score, the WFH score failed to detect any changes 
post- intervention. Change in scores was detected only in the PROMs the HAQ and 
the WOMAC.205 The responsiveness as rated on the 4-point COSMIN checklist192 was 
‘poor.’ This was due to the small sample size (item 3) and due to the lack of description 
of the time interval (item 5) in which responsiveness to change was assessed. There 
were no additional properties that were reported by the authors of the FISH score. 
3.2.2.3 Other properties evaluated  
The evaluation of the interpretability of the scores enabled only two aspects to be 
completed, which were the distribution of the total scores (7-32) and the percentage of 
respondents with the highest possible score (9.5%). Results of the generalizability are 
summarised in table 8. Precision for the FISH is poor in that it only has 4 response 
options which allows for scoring the level of assistance required whilst performing a 
task.  
The manuscript for the questionnaire provides moderate information regarding the 
conceptual model. It only defines the construct as function, in a performance based 
assessment context. Thus this vague description of a construct entails moderate 
evaluation of this property. The measurement model of the FISH was not defined but 
it was defined as a reflective model since the instrument assesses ADL and as the 
‘thought test’ indicated that the items changed as the construct changed. The FISH 
carries more investigator burden than it does with regard to patient burden. As the 
FISH is a performance based instrument it takes 15 minutes to complete the 8 items 
and the response rate of the FISH was 100%. The Flesch reading ease score was 58.4, 
which means ‘fairly difficult to read’, and the Flesch-Kincaid grade is between 10th-
12th graders.159 The FISH questionnaire is feasible and has been accepted as it has been 
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implemented in practice for almost a decade. The FISH questionnaire is available to 
the public, and is available via the WFH website. 
(http://www.wfh.org/en/page.aspx?pid=875) Since the FISH is a performance based 
instrument it requires training of the investigator to ensure correct administration and 
assessment of the questionnaire. This training comes at no cost in the guidance to users 
of the instrument. 
3.2.3 HEP-test-Q score 
This score was produced by a German group led by von Mackensen et al20 as a part of 
the Haemophilia and Exercise Project (HEP) in 2009. This HEP-Test-Q is PROM 
based on motor abilities. It can be applied in sports therapy where the focus is on 
prevention of injury and to rehabilitate. This assesses physical status under the 
categories of 
1.     Mobility 
2.     Strength and coordination 
3.     Endurance 
4.     Body perception (wellbeing, exposure of stress, self-esteem). 
It consists of 25 items and the answers are filled in a 5 point Likert scale of 1 (never) 
to 5 (always).20 The HEP-Test-Q is linguistically validated in German, English and 
Italian. Additional versions in Dutch, Greek, French and Spanish are available.20 This 
systematic review evaluated the German version of the HEP-Test-Q. The HEP-Test-
Q pilot validation studies had sample sizes of 24 and 43 patients respectively.196 The 
English HEP-Test-Q is shown in appendix 4. 
3.2.3.1 Development of the HEP-Test-Q 
 
Item generation involved selection of items using professionals in sports medicine. 
Further information on these participants and methods were not available.196 
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3.2.3.2 Measurement Properties 
The total value for internal consistency as calculated by Cronbach’s alpha was 0.96. 
This varied from 0.85-0.92 across each dimension assessed.196 Internal consistency as 
evaluated by the COSMIN 4-point checklist192 received a rating of ‘poor’ as factor 
analysis was not performed or as there was no reference to another study (item 5) and 
the sample size was <5 participants per item for the assessment of unidimensionality 
(item 6). Test re-test reliability was assessed using Pearson's correlation coefficient 
which received a value of 0.90 (p <0.001) for the total score.196 This parameter was 
assigned a ‘fair’ due to the sample size included in its assessment (item 3) and because 
even though the correlation coefficient was calculated there was no evidence that 
systematic change had not occurred (item 11). The measurement error for absolute 
measures was administered a ‘fair’ rating due to its sample size (item 3).  
A content validity study was carried out at the pilot stage where patients rated for the 
preliminary version of the score on a scale from 0 (not important) to 100 (very 
important) which gave a mean score and standard deviation of 66.8 ±19.6 (range 12-
98).196 Thus the evaluation of the pilot version of the questionnaire gave a ‘good’ rating 
for the content validity as the purpose of the instrument was not described but assumed 
(item 3). 
Convergent validity as described by the authors was tested against the Haem-A-
QoL185, HAL202 and the SF-36PCS206 scores. The correlation coefficients for such 
measurements and the total HEP-Test-Q score were -0.82, 0.76, -0.71 respectively.196 
Convergent validity defined by the authors met the COSMIN definition of structural 
validity.153 This scored ‘poor’ as the sample size in the analysis included <5 
participants per item (item 4) and no exploratory or confirmatory analysis was 
performed (item 6). Hypothesis testing in the COSMIN checklist192 was rated as ‘fair’ 
65 
 
because of the moderate sample size (item 3) and the hypotheses were not formulated 
but it was possible to deduce what was expected (item 4). Cross cultural validity is not 
applicable to the original German version of the HEP-Test-Q whereas criterion validity 
is not applicable to this as it is a PROM. 
Responsiveness was assessed in a separate study that evaluated those patients that 
underwent regular hydrotherapy. At 6 and 12 months follow up the physical 
examination score, the WFH Orthopaedic Joint Score (OJS) detected a significant 
change (6 months p<0.035,12 months p<0.024). However, the HEP-Test-Q was unable 
to detect a significant change in follow-up during both follow up times. This was rated 
‘poor’ on the COSMIN 4-point checklist192 because of the small sample size (item3). 
3.2.3.3 Other properties reported 
Authors evaluated discriminant validity in those with certain clinical characteristics. 
Significant differences were only associated with age (≤40 years versus >40 years), 
Hepatitis A (yes versus no), HBV (yes versus no) and the number of target joints (0 
versus ≥1).196 
In a subsequent study the HEP-Test-Q score was compared against objective 
measurements which included: ROM, one leg stand and the 12- minute walk test.207 
Spearman rank correlation coefficients were calculated for the relationships which 
were all significant between the total HEP-Test-Q at the level of P<0.001. The highest 
correlation was in the 12 minute walk test (0.757) while the lowest correlation was the 
left sided one leg stand (0.403).207  
3.2.3.4 Other properties evaluated 
Interpretability of the final HEP-Test-Q was poor as it did not provide any data for the 
reader to interpret values from the validation study. Results for the generalisability of 
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this instrument are summarised in table 8. The precision of the scores are rated on a 5 
point scale based on the ability to perform a task and agreement with a statement. The 
conceptual model adopted in the HEP-Test-Q was depicted as a sports oriented score 
to assess function However, the measurement model was not clearly stated by the 
authors. The ‘thought test’ suggested that this instrument had elements of both 
reflective and formative models. With regards to burden this instrument takes an 
average of 14.4 ± 9.6 minutes to complete the 25 items. The response rate was 79%.196 
The Flesch reading ease score was 56.3, which is ‘fairly difficult to read’ and the 
Flesch-Kincaid grade level was between 10th-12th grades.159 Even though this PROM 
is relatively new, it is feasible and accepted in those whom it has been used on. The 
HEP-test-Q is currently not freely available to the user thus limiting its use to those 
interested. However, upon contacting the author this PROM could be requested. As 
this instrument is a PROM it requires no training.  
3.2.3.5 English Version 
In the literature of the HEP-Test-Q score it is stated that the original was developed in 
German and that additional translated versions including the English version was 
validated. Thus a broader search was attempted to find this validated English version 
of the HEP-Test-Q. A poster that was presented at the WFH world congress in 2014 
identified a partial validation study.208 The results of this English HEP-Test-Q are 
presented below. The full COSMIN checklist was not applied to this PROM as it did 
not evaluate most measurement properties. Instead the cross cultural validation box in 
the 4-point COSMIN checklist192 was applied to evaluate the integrity of cross cultural 
validation of this translated instrument.  
The translation process undertaken was a forward/backward method and the expertise 
of those involved in the translation was not described. The translated instrument was 
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administered to English speaking communities in the United States and the UK.208 The 
total of participants were 38 (total mean age 15.8 ± standard deviation 9.7) where 9 
were adults (mean age 29.8 ± standard deviation 10.2) 29 were children (mean age 
11.5 ± standard deviation 3.4). The internal consistency as assessed by Cronbach’s 
alpha value was 0.916 and this ranged from 0.729-0.891 across the dimensions of the 
HEP-Test-Q score.208  
When applying the cross cultural validity box in the COSMIN checklist192 the 
translated version scored ‘poor’. As the sample size included was < 5 participants per 
item (item 3), the instrument was not pre-tested in the form of cognitive interviews 
(item 10), the samples were not similar for all characteristics except language or 
culture (item 12) and confirmatory factor analysis was not performed in this population 
(item 14).   
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Table 8 Generalisability results of studies 
Instrument/ 
Author 
Year Language 
evaluated 
Country of 
development 
Instrument 
type 
Sample 
size 
Mean 
age 
(SD) 
Haemophilia Disease severity Study 
setting 
Type 
B 
(%) 
Type 
A 
(%) 
Severe 
(%) 
Moderate 
(%) 
Mild                
(%) 
HAL/ Van 
Genderen 
2006 Dutch Netherlands PROM 127 42      
(12.5) 
17  
(13) 
110    
(87) 
127 
(100) 
- - Secondary 
care 
FISH/ 
Poonoose 
2007 English India Performance 
based 
assessment 
63 14        
(8.3) 
5      
(8) 
58      
(92) 
63 
(100) 
- - Secondary 
care 
HEP-Test-Q/ 
von 
Mackensen 
2010 German Germany PROM 43 44      
(11.5) 
3      
(7) 
40      
(93) 
38  
(88) 
3             
(7) 
2    
(5) 
Secondary 
care 
Abbreviations: SD- Standard Deviation, HAL- Haemophilia Activities List, FISH- Functional Independence Score in Haemophilia, HEP-Test-Q- Haemophilia 
Exercise Project-Test-Questionnaire, PROM- Patient Reported Outcome Measure 
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Table 9 Evaluation of measurement properties using the COSMIN 4-point checklist 
Instrument/ 
Author 
Internal 
consistency 
Reliability Measurement 
error 
Content 
validity 
Structural 
validity 
Hypothesis 
testing 
Cross 
cultural 
validity 
Criterion 
Validity 
Responsiveness 
HAL/ Van 
Genderen 
Poor (6) N/A N/A Good (2,3)* Poor (4) Good (1,2,4) - - N/A 
FISH/  
Poonoose 
Poor (5,7) Fair (2,10) Fair (2,6,8) Poor (1,2) Poor (6) Fair (4) - Good (3,4) Poor (3,5) 
HEP-Test-Q/ 
von 
Mackensen 
Poor (5,6) Fair (3,11) Fair (3) Good (3) Poor (4,6) Fair (3,4) - - Poor (3) 
The number in brackets () indicate the item number on the 4-point COSMIN checklist that corresponds to the lowest rating obtained. 
* Pilot study results 
Abbreviations: HAL- Haemophilia Activities list, FISH - Functional independence score in Haemophilia, HEP-Test-Q- Haemophilia Exercise project  test 
Questionnaire, 
N/A - not assessed ;‘–’ not applicable 
Underlined numbers mean that the item number on the 4-point COSMIN checklist after excluding items that are affected by a small sample size 
 
70 
 
4 CHAPTER 4- Discussion  
 
 
4.1 Literature search 
 
The literature search was broad in terms to detect all the available instruments used to 
assess function in adult persons with haemophilia. Those selected in the systematic 
review were instruments that were disease specific for the adult persons with 
haemophilia. Disease specific instruments have the advantage over the generic 
instruments as they contain items that are sensitive to the disease and higher content 
validity thus having a high discriminating value. Whereas patients are more likely to 
lose interest by lengthy instruments or distracted by non-specific items, both features 
of generic instruments.  This leads to high acceptability. In addition such disease 
specific measures are the most responsive to clinical changes in the disease.209 The 
construct of interest was function, which resulted in the inclusion of PROMs and 
performance measures. The physical examination scores were excluded as they do not 
detect function. The construct function was decided as the focus as physical 
examination scores do not necessarily correspond to a patient’s ability to function and 
perform tasks. Joint specific scores were excluded as haemophilia is a systemic disease 
affecting multiple joints. Therefore, it would only be right to identify instruments that 
evaluate function of all limbs.  
  
4.2 Critical appraisal tool  
 
Since the implementation of measurement instruments, there has been a large array of 
tools produced to assess such instruments.154, 210 The most recent and relevant 
examples of such tools, are the COSMIN checklist 152 and the International Society for 
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Quality Of Life research (ISOQOL)155 minimum requirements for the evaluation of 
measurement properties of a PROM. In 2013 ISOQOL155 published a set of minimum 
requirements that should be met in PROM research indicating that if PROMs do not 
reach the recommended minimum standards it should not be considered appropriate 
for use in clinical practice. However, the authors go on to state that this does not hinder 
the instrument developers from adopting a maturation model to further validate and 
strengthen the questionnaire. The ISOQOL standards155 were based on guidelines 
obtained from expert opinion and literature, which included the COSMIN checklist. 
This highlighted that when selecting a PROM the process of its conceptual and 
measurement model, reliability (internal consistency reliability, test-retest reliability), 
validity (content validity, construct validity, criterion validity and responsiveness); 
interpretability of scores and patient and investigator burden should be considered.155 
Definitions of each minimum standard as described in the ISOQOL is included in 
appendix 5.  
The COSMIN checklist is a very comprehensive and rigorous checklist that focuses 
on measurement properties and methodological properties of a PROM. In addition to 
its checklist, the COSMIN checklist is accompanied by an associative COSMIN 
taxonomy, which supplements its use. It has been widely used throughout literature 
but this rigorous checklist comes at the expense of its complexity to the user.152  
Since the ISOQOL was a standalone study it did not produce uniform definitions such 
as how the COSMIN initiative produced. In addition the ISOQOL does not produce 
guidance on how to evaluate the methodology of each property. Therefore the 
COSMIN 4-point checklist was used to evaluate the measurement properties of each 
instrument. 
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4.3 Evaluation 
 
All three haemophilia specific functional scores the HAL, FISH and the HEP-Test-Q 
produced for the adult population have undergone pilot studies and a subsequent 
validation studies to assess their measurement properties. The HAL was validated in 
the largest population (n=127) which was twice as large as the population in which the 
FISH was validated in (n=63). The HEP-Test-Q was validated in the smallest sample 
(n=43).  
4.3.1 Development of instruments 
Concerning the development of instruments, each instrument employed different 
techniques in its development. The HAL provided sufficient information to the reader 
to be able to interpret data such as information on the semi-structured interviews for 
item generation, which was unavailable for other instruments. The HAL and the HEP-
Test-Q involved the participation of only one group of participants (patients and 
healthcare professionals respectively). A patient centred approach was not 
incorporated to the development of the HEP-Test-Q. This was settled by seeking 
patients’ opinion on missing items after the professionals generated the items.196 The 
FISH obtained the input of patients, relatives and healthcare professionals for the item 
generation stage. The data presentation regarding the development of the instruments 
FISH and HEP-Test-Q were poor, as it did not give sources of information, such as 
interviewing and the distribution of participants involved in this stage. The importance 
of the involvement of patients in the development of PROMs was highlighted by 
Wiering et al.211 They suggest that since there has been no changes in the involvement 
of patients over time211 this trend should change by giving patients the preference.  
73 
 
4.3.2 Measurement properties of instruments 
As a whole, evaluation of the instruments using the COSMIN 4-point checklist 
depicted that none of the instruments contained an ‘excellent’ in its measurement 
properties. As haemophilia is a rare disease authors run into challenges in obtaining 
large sample sizes which is a specific requirement in obtaining a high rating in the 
COSMIN checklist. Where the sample size has influenced a low rating, these values 
have been underlined in table 9. 
No author of any of the instruments has clearly described the measurement model 
indicating if the instrument is a formative or a reflective model. This has implications 
on the evaluations on certain measurement properties such as internal consistency 
because in formative models this is not assessed.151 The COSMIN manual advises 
investigators to apply a ‘thought test’ to decide on the measurement model.193 This test 
was applied to all three instruments and the HAL and the FISH were found to be of a 
reflective model as they assessed ADL. Whereas the HEP-Test-Q consisted of a mixed 
model of both reflective and formative models as they measured ADL and factors that 
influence function. There is no description in the COSMIN manual on how to evaluate 
a mixed model. Therefore as the authors of the HEP-Test-Q score assessed internal 
consistency and used this as a basis for item reduction this measurement model in the 
HEP-Test-Q was treated as a reflective model.  
With regards to internal consistency, all instruments obtained a rating of ‘poor.’ Both 
instruments HAL and HEP-Test-Q were influenced by small sample size. If the sample 
size items were eliminated the HAL would obtain a ‘good’ rating while the HEP-Test-
Q would receive a rating of ‘fair’. Item number 5 in the COSMIN checklist for internal 
consistency was rated ‘poor’. This item was excluded as it focuses on factor analysis 
and to perform factor analysis a sample size of >100 is often required.212 The 
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Cronbach’s alpha value for internal consistency for the HAL and the HEP–Test-Q 
scores took values of 0.96 and 0.97 respectively. It has been suggested that if a 
Cronbach’s alpha value >0.9 has the possibility of redundancy as items may be 
remarkably similar.158 This suggests that the lengthy instruments could assess 
parameters with less items than what is included.   
Reliability was not assessed in the HAL while the other two instruments received ‘fair’ 
ratings for its assessments for reliability. As FISH is a performance measure it is 
unclear in the reporting of data by the authors if it were for intra-rater reliability or 
inter-rater reliability as both parameters were assessed. Since the statistical analysis 
only produced a pooled ICC, it was assumed that a collective mix of both intra-rater 
and inter-rater reliability were reported. Data presentation of the FISH is inadequate 
in that it does not present much data to be able to draw proper conclusions regarding 
this matter. This affected the methodological integrity evaluation of the study (item 
10). The HEP-Test-Q had a low sample size affecting its rating. Since the Pearson 
correlation coefficient was calculated (item 11), the value for overall rating of the 
measurement property reliability remained the same at ‘fair.’ 
As measurement error is a measurement property that is an extension of the domain of 
reliability, it mirrored the results of the reliability study. It should be stated that no 
instrument calculated limits of agreement or standard error of measurement but this 
could be calculated in the HEP-Test-Q from the data provided (item 11).  
Content validity was formally assessed in the HAL and the HEP-Test-Q scores, which 
had ‘good’ ratings in the COSMIN 4-point checklist. In spite of the assessments of 
sample size, all three instruments had the down side of not clearly stating the purpose 
of the instrument (item 3). The content of the HAL was assessed by administering a 
scale to both patients and physical therapists. A drawback in this content study was 
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that the patients reviewed the content of the Dutch version of the HAL whilst the 
physical therapists assessed the content of the English version. In the evaluation of the 
COSMIN 4-point checklist, the English version was not carried out, as the content 
validity was the only measurement property evaluated in that instrument, indicating an 
inadequate validation process. The content of the HAL was only evaluated at the pilot 
stage indicating that this content was assessed in the preliminary version of the 
instrument. The content study of the HEP-Test-Q only had a moderate correlation as 
it had a mean score of 66.8 out of 100. No content study was carried out for the FISH 
score, yet the COSMIN checklist was applied for this property as the authors stated 
that it possessed sufficient face validity. The FISH scored a ‘poor’ rating for the 
measurement property, content validity. 
All instruments received a rating of ‘poor’ for the measurement property of structural 
validity. Overall the reason for this value to be taken was a low sample size (item 4) 
and/ or no application of factor analysis (item 6).  When these items were excluded, 
all three instruments would score ‘good’ for structural validity. The HAL was 
validated against the Dutch-AIMS2 and the IPA. The initial version Dutch-AIMS was 
developed for the use in rheumatoid arthritis.213 It has been validated for the use in 
severe haemophilia.214 The IPA addresses the personal impact of disease on 
participation, autonomy and related experience of problems.200, 215 This questionnaire 
has not been validated to be used on the haemophilic population. The authors’ 
justification for the use of the IPA was that it consisted of similar Cronbach’s alpha 
value as the developed HAL thus providing it to be a suitable reliability index in this 
disease.194 The structural validity of the FISH was assessed using the WFH and 
Pettersson scores, even though both these scores are validated in the target population 
it is questionable as to whether it assesses the same construct. The structural validity 
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of the HEP-Test-Q was assessed using two validated instruments in the haemophiliac 
population (Haem-A-QoL and HAL) and one instrument that was not validated in a 
haemophiliac population, the SF-36. It should be noted that the Haem-A-QoL and SF-
36 measures the construct HR-QoL as opposed to function. As the SF-36 provides a 
physical score (the SF-36PCS) on function this domain was only used to validate the 
HEP-Test-Q.  
Hypothesis testing was best assessed in the HAL which received a ‘good’ while the 
other two scores received ‘fair’ ratings. This indicates that the FISH and the HEP-Test-
Q had not focussed on providing hypotheses.  
Cross-cultural validity was not applicable to the PROMs HAL and the HEP-Test-Q 
instruments as their original versions (in Dutch and German) were evaluated. Even 
though the respective English instruments were available, cross–cultural validation 
was not formally assessed as the complete validation of the English instruments had 
not taken place. The performance based instrument FISH was developed by the authors 
to avoid this translator issue among different populations. Thus questioning the need 
for cross-cultural validation in this instrument. The methodological integrity of the 
translated versions of the HAL and the HEP-Test-Q should be evaluated. The authors 
of the HAL used the ICF classification system to classify the items in the Dutch HAL 
and subsequently matched the code to the English version of the ICF classification 
system. This was used as the basis of the translation of the instrument.  No form of 
validation of the English instrument was performed apart from the aforementioned 
content study. This is seen as a major drawback of the English version of HAL. The 
cross cultural validation of the HEP-Test-Q obtained a ‘poor’ rating which would 
probably be due to the fact that data presentation was through a poster presentation as 
opposed to a published article. The English HEP-Test-Q was studied only on a small 
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sample of adult persons with haemophilia (n=9), as majority were children (n=29). 
The translated instrument was assessed only by testing for internal consistency as a 
measurement property. Therefore this English HEP-Test-Q has not undergone full 
validation.  
Criterion validity is not applicable to the PROMs HAL and HEP-Test-Q as neither of 
these instruments has been produced from a previous longer version of the same 
instrument. However criterion validity is applicable to the FISH as it is a performance 
based instrument. This measurement property did receive a rating of ‘good’ but it is 
unclear if the criterion used was in fact an adequate ‘gold standard’ measurement of 
the construct being measured. The authors used PROMs to assess function, which is 
known to be a subjective assessment of function. The HAL was the only validated 
instrument in haemophilia whereas the WOMAC and HAQ scores have not been 
validated in persons with haemophilia. However, the HAL was only validated in a 
Dutch speaking adult population. The mean age of the validated population suggests 
that the FISH instrument was validated in a predominantly paediatric population. 
Information regarding the language version of the PROM, HAL was not provided by 
the authors of the FISH, which is vital information to make proper conclusions 
regarding this validation process.  
Responsiveness to change was only assessed as a part of the original validation study 
in the FISH whereas the responsiveness of the HEP-Test-Q was evaluated in a 
subsequent study.216 The instruments that detected change in the joints in the FISH 
responsiveness study, HAQ and WOMAC have not been validated for the use in 
haemophilia. In the HEP-Test-Q responsiveness study change was detected only by 
the WFH orthopaedic joint score (OJS).216 The OJS is a physical score and does not 
assess the same construct, function. Other instruments (Haem-A-QoL and SF-36), 
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which include the HEP-Test-Q, did not show significant results post-intervention thus 
questioning the responsiveness of the HEP-Test-Q. As this study was carried out in 
2010 prior to the presentation of results of the English HEP-Test-Q (2014) it was 
assumed that responsiveness was assessed in the German instrument. When applying 
the COSMIN checklist the HEP-Test-Q received a ‘poor’ rating which was due to the 
small sample size (item 3). If this factor were to be excluded the HEP-Test-Q would 
receive a rating of ‘fair’ for not forming proper hypotheses (item 8) and other minor 
flaws in the methodology of the study (items 13,16). The assessment of the 
methodology of the study is irrelevant as it shows that the HEP-Test-Q is not 
responsive. The HAL has not been assessed for responsiveness to change. There was 
a case series of three patients, which evaluated ankle distraction. Nevertheless this 
study was excluded in the analysis of responsiveness as the indication for intervention 
was not genuine haemophilic arthropathy but secondary causes such as trauma in 
haemophililacs.217 The two instruments that assessed responsiveness, the FISH and 
HEP-Test-Q do not assess functional status if it were to get worse (i.e. following 
haemarthrosis), or more pronounced intervention required (i.e. joint replacements). 
Responsiveness is an important aspect especially if an instrument needs to be used in 
longitudinal studies and assess outcomes.153, 218 The evidence of responsiveness 
remains crucial to make adequate assessments using a PROM.  
4.3.3 Other properties 
Interpretability of scores in all three instruments were poorly presented. This is an 
aspect that should be clearly improved in each instrument even though it is not a 
measurement property. Attention should be given by authors to the missing items and 
to how these were handled. In addition the distribution of scores, the percentage of 
respondents with the lowest and highest scores, and distribution of scores for each 
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subgroup should be presented. Another critical value that should be presented is the 
minimal important change or minimal important clinical difference of the instrument. 
This allows accurate interpretation to be made regarding what is important to the 
patient.219 The advantage of using a disease specific instrument is that clinically 
important changes can be assessed209, however if the instruments do not provide 
information to interpret these values the instrument fails to stay true to its purpose.  
The generalisability results suggested that there was an important difference between 
the populations in which the instruments were validated. The mean age for the HAL 
42 years (standard deviation ±13) and the HEP-Test-Q 44 years (standard deviation ± 
12) were similar. Whereas the mean age for the FISH score was 14 years (standard 
deviation ±8) indicating that this instrument was validated in a mixed population, 
skewed more towards the paediatric population. In addition the FISH was developed 
and validated in India, a developing nation that has a more severe form of joint disease 
than those in the western world due to the limited treatment modalities and resources 
available. This suggests that the FISH score is sensitive to a more progressive 
arthropathy. This limitation was acknowledged by the developers of the FISH.195  
The HAL had the best precision out of all instruments while the HEP-Test-Q was next 
in line. The applicability of a more precise response category is questionable to a 
performance based instrument such as the FISH. It should be noted that the precision 
of the items on the instrument may have been confounded by the degree of joint disease 
seen in the validated population of the FISH.  
The construct assessed in all these instruments were function. The conceptual model 
varied between each developer indicating that each instrument was subjected to 
changes by the developer. The HAL and the FISH are similar in that they categorised 
items into the ICF classification. The HAL only included those under the 'activities' 
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domain while FISH included any activity only excluding those that could not be 
assessed in a clinic setting. HEP-Test-Q score is a sport oriented score that focuses 
mainly on the lower limbs. The measurement model for the HAL and the FISH score 
was a reflective model as all these scores assessed ADL. The HEP-Test-Q was a mixed 
model of both formative and reflective models as its items possess both indicators and 
effectors. It is indeed necessary to incorporate both the formative and reflective aspects 
of function, as the reflective model of function will only measure the homogenous task 
specific actions. This limitation calls for a mixed model incorporating both formative 
and reflective models. The HEP-Test-Q assesses a wider construct of function as 
opposed to the other two instruments.  
Evaluating patient and investigator burden revealed that even though the HAL was 
quite detailed it came at the expense of its length. To ascertain the willingness of a 
patient to complete a questionnaire, the items should be relevant and the list as short 
as possible as it poses a threat to the acceptability. As the FISH is a performance based 
questionnaire it takes longer to be filled in by the investigators than the HEP-Test-Q, 
which is short, hence takes less time to fill in. All instruments had good response rates 
noting that the FISH is not a PROM. It should be noted that acceptability as assessed 
by response rate could be influenced by other causes of disability (physical or mental), 
current health status and the mode of administration.154, 220 The Flesch reading ease 
score for each of the existing scores came above the recommended standard indicating 
that each was too high. Since the FISH is administered by the clinician, and not a 
PROM the Flesch reading ease score was disregarded. The high reading ages in the 
HAL and the HEP-Test-Q scores could be regarded to be the cause of the fact that 
neither of the scores was properly translated and cross culturally validated in an 
English speaking population. All instruments were well accepted by the population in 
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which it was studied on and were practicable instruments. The HAL and FISH have 
been in practice for at least a decade and are freely accessible. However to obtain the 
HEP-Test-Q it is mandatory to contact the developer. This fine analysis suggests that 
HAL has more patient burden than investigator burden. In contrast the FISH has more 
investigator burden than patient burden. Both of these facts are self-explanatory due 
to the nature of each instrument. The HEP-Test-Q has a relative burden on both parties, 
which may be seen as a shortcoming of this instrument. 
4.3.3.1 Health literacy and language  
The ability to understand and the capacity to process and obtain basic health 
information, and access to services needed to make appropriate health decisions is 
known as the health literacy of a patient.221 This encompasses skills such as reading, 
comprehension, listening, analysing and decision making. Functional health literacy is 
crucial as it enables effective communication between the healthcare providers and 
patients.222 To address this issue healthcare professionals have attempted to bridge this 
gap through communicating. However, when implementing a self-administered 
questionnaire, this may deem arduous . This is by far the biggest challenge encountered 
by even the best developed PROM that consist of excellent measurement properties.223 
Most of the existing PROMs require a considerable amount of cognitive work by 
patients when selecting responses to each item, the main reason behind this being the 
phrasing of each item.224 This is seen as a principal cause for non-response.154  
Although individuals with high levels of health literacy have the necessary skills to 
make decisions using health information, inaccuracies arise when those with low levels 
of health literacy struggle in this process and hence are more likely to contribute to 
poor outcomes.221 The literature has highlighted that cohorts that are more likely to 
have low levels of health literacy are those in the older age range225-229, minorities221, 
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230, 231, low socioeconomic status221, 228 and low levels of education221, 228, 232. Thus it 
is vital that PROMs accurately address these health literacy levels by ensuring that the 
language of such instruments are not complex and has the ease of understanding. 
Ambiguous items in a questionnaire may result in responses that are inaccurate 
representations of the participants’ views or may even lead to missing responses. 
Health literacy is not the only culpable factor in this case but also other circumstances 
such as using phrases with alternative meanings, which are unfamiliar to the subject. 
Thus at item generation and questionnaire design, one should use plain, lay language 
to address the varying levels of education and experience of respondents.  This is the 
only way to ensure that a vast majority of respondents would be able to understand the 
items. Throughout the literature it has been cited that items should be written in a way 
that could be comprehended by a 12 year old child.158 To assess the reading ease of a 
questionnaire in English Flesch-Kincaid readability tests have been produced.233  
Other tactics to be included whilst developing a questionnaire are avoiding any 
negative wording, including items that are specific, and ensuring that each item 
contains only one question.149  
The information that is obtained using a PROM is only valid if the participants can 
understand what is being asked of them which enables the healthcare professional to 
obtain data about the patient that reflect subject experiences, health status or 
perspective. Excess cognitive efforts of the patient, results in confusion. This leads to 
an inaccurate answer be in given to the intended question or a longer response time as 
the patient attempts to comprehend what the investigator intends on measuring. 
Therefore, it is of paramount importance to ensure that the items on the questionnaires 
are clear and easy to understand.  
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4.4 Assessment of joint disease 
It is evident that even though the mentioned instruments assess joint function they are 
very different in what they assess. The HAL and the FISH assess ADL whereas the 
HEP-Test-Q assesses ADL and factors that influence function. The HAL and HEP-
Test-Q are PROMs whereas the FISH is a performance based assessment.  
A study234 showed that the inter-rater reliability between different healthcare 
professionals that assessed disability using performance based assessments 
werepoor.234 This indicates that performance tasks lack uniformity in practice as 
different professions may have varying levels of expectations depending on to their 
healthcare role. In order to minimise these careful instructions, and/or induction 
courses on how to use such tools are carried out but this is time consuming and 
expensive. Other disadvantages in these performance measures would be the 
practicality of such tests in a clinical environment that may be rushed for time, and 
space required to perform the tasks. Pinheiro et al143 evaluated PROMs and 
performance based measures in patients with arthritis. They revealed that PROMs have 
the capacity to unravel domains that a performance task is unable to do. In addition 
PROMs accurately represent overall function as these provide a platform for the 
patient to discuss their personal functional experiences.143 
PROMs are an essential way of assessing function, as it has proven useful in routine 
practice and clinical research to inform the effectiveness of interventions. A well-
developed PROM, provides a good foundation for healthcare professionals in making 
an informed decision about patient care and to evaluate the safety and effectiveness of 
interventions.136 In the absence of PROMs it would be difficult to weigh up the risks 
and benefits of management options on outcomes other than mortality.132 PROMs do 
carry the risk of the ‘normative social effect’ where often the patients fill in items based 
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on what the healthcare professional would want to hear. This overclouds the actual 
functional status of the patient. PROMs are used to make comparisons between the 
outcome of care received and efficacy to allow clinical decision making as 
investigations would do.137 Studying the HAL and the HEP-Test-Q showed that even 
though both these PROMs assess the same construct they are very different 
instruments in terms of what they assess. The broader construct of function, which the 
HEP-Test-Q assesses, proves to be vital even though the ADL that it assesses remain 
vague. Close attention should be paid to the personal and environmental factors that 
influence one’s function which is a part of disability model described by the ICF. A 
broader construct often requires a mix of the formative and reflective measurement 
models. Inclusion of a broader construct comes with its own problems, which revolves 
around the psychometric analysis of the measurement properties. With haemophilia 
being a rare disease obtaining the necessary sample size for complex statistical analysis 
such as factor analysis for such mixed model proves to be the biggest hurdle.   
Other methods of evaluation of joint disease such as physical examination tools, 
imaging scores and QoL measures prove important as they provide unique aspects of 
joint disease to be assessed by the healthcare professional as these measure different 
constructs. PROMs to date remain a preferable method to obtain a good representation 
of joint health and a well refined method of prognostic information. Nevertheless, it 
should be emphasised that a PROM will not be able to solely measure joint disease 
and should be used to complement other instruments that assess different constructs of 
joint disease as each instrument has different influencing factors.235, 236  
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4.5 Limitations 
The PRISMA guidance was followed throughout this study wherever possible. The 
only instance in which this could not be followed was data collection stage in the 
methods. The input of an additional investigator would have been beneficial in the 
study selection. However, this did not compromise the detection of available 
instruments that assess function in adult haemophilia.  
A limitation in this study is that analysis of the instruments was done using the 
COSMIN checklist, which is a PROM guidance. It should be reiterated that the FISH 
in fact is not a PROM. This was still used for uniformity as there is no rigorous 
appraisal tool to evaluate the methodological quality of performance based 
instruments. It should be noted that the COSMIN group is currently in the process of 
producing such a guidance tool to be utilised by researchers.  
The COSMIN checklist has the drawback of only evaluating measurement properties. 
To minimise this effect other properties mentioned in the literature were identified and 
evaluated. However this is affected by measurement bias as there is no standardised 
method to evaluate such properties. It is thought that it would be better if the author 
assessed these ‘other properties’ as opposed to not assessing thus this was carried out.  
The readability formulae only take into account the word length and neglects 
vocabulary. As a result, one should not rely on this method exclusively. However as 
there is no other way to assess readability and as these formulae are the tools most 
widely used in medical literature, they were used to assess readability.237  
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5 CHAPTER 5- Further Study and Conclusions 
 
 
5.1 Further study 
 
This systematic review revealed that there is a need for a new PROM to assess function 
in the English speaking adult persons with haemophilia. One may question why not 
fully cross-culturally validate or improve the existing PROMs to an English speaking 
population. This is definitely a feasible option as highlighted above, the construct and 
the items of the existing instruments assess a narrow niche. Therefore it deems feasible 
that a new PROM is developed for this population to assess function in a holistic 
manner. A three part study has been designed addressing the drawbacks of the existing 
instruments, to develop and validate a novel PROM. This study has been presented for 
an ethical review under the research ethics committee reference 16/NW/0532 and has 
been given ethical approval. It is currently undergoing the Health Research Authority 
(HRA) process.  
 
5.2 Conclusion 
 
The existing functional scores consist of satisfactory measurement and other properties 
but not all properties have been assessed by the developers. Applying the COSMIN 4-
point checklist provided a comprehensive approach to investigate the measurement 
properties indicating that the methodological quality varied significantly between each 
property and instrument. Even though the COSMIN checklist was applied to the FISH 
the results should be interpreted with caution as it is a performance based instrument. 
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The HAL had the least amount of measurement properties assessed, but had better 
ratings on the checklist than the FISH and the HEP-Test-Q.  The English versions of 
the PROMs HAL and HEP-Test-Q had not undergone full cross-cultural validation 
and had high readability scores. The HAL and the FISH assessed function only as ADL 
whereas the HEP-Test-Q assessed function broadly. None of these models have taken 
into account the full disability model of ICF.  
The narrow niche measured should be broadened to assess function in a holistic 
manner to incorporate the full disability model and the views of patients. PROMs play 
an important role in obtaining the perspective of a patient with a chronic disease such 
as haemophilia. There is a need for a validated PROM to assess function for the 
English speaking persons with haemophilia. This systematic review and critical 
appraisal was carried out as a part of preliminary work for the development of a novel 
instrument that aims to look at a disease specific PROM for the adult population. The 
shortcomings of the existing scores will be addressed in this novel PROM that will 
assess function in this population.   
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7 APPENDICES  
 
7.1 Appendix 1- COSMIN table of definitions129 
 
Term 
Definition 
Domain 
Measurement 
property 
Aspect of a 
measurement 
property 
Reliability   The degree to which the measurement is free from 
measurement error 
Reliability  
(extended 
definition) 
  The extent to which scores for patients who have 
not changed are the same for repeated 
measurement under several conditions: e.g. using 
different sets of items from the same health 
related-patient reported outcomes (HR-PRO) 
(internal consistency); over time (test-retest); by 
different persons on the same occasion (inter-
rater); or by the same persons (i.e. raters or 
responders) on different occasions (intra-rater) 
 Internal 
consistency 
 The degree of the interrelatedness among the items 
 Reliability  The proportion of the total variance in the 
measurements which is due to ‘true’† differences 
between patients 
 Measurement 
error 
 The systematic and random error of a patient’s 
score that is not attributed to true changes in the 
construct to be measured 
Validity   The degree to which a PROM instrument measures 
the construct(s) it purports to measure 
 Content validity  The degree to which the content of an PROM 
instrument is an adequate reflection of the 
construct to be measured 
  Face validity The degree to which (the items of) an PROM 
instrument indeed looks as though they are an 
adequate reflection of the construct to be 
measured 
 Construct 
validity 
 The degree to which the scores of an PROM 
instrument are consistent with hypotheses (for 
instance with regard to internal relationships, 
relationships to scores of other instruments, or 
differences between relevant groups) based on the 
assumption that the PROM instrument validly 
measures the construct to be measured 
  Structural 
validity 
The degree to which the scores of an PROM 
instrument are an adequate reflection of the 
dimensionality of the construct to be measured 
  Hypotheses 
testing 
Idem construct validity 
  Cross-cultural 
validity 
The degree to which the performance of the items 
on a translated or culturally adapted PROM 
instrument are an adequate reflection of the 
performance of the items of the original version of 
the PROM instrument 
 Criterion 
validity 
 The degree to which the scores of an PROM 
instrument are an adequate reflection of a ‘gold 
standard’ 
Responsive
ness 
  The ability of an PROM instrument to detect change 
over time in the construct to be measured 
 Responsiveness  Idem Responsiveness 
122 
 
Interpretab
ility* 
  Interpretability is the degree to which one can 
assign qualitative meaning - that is, clinical or 
commonly understood connotations – to an 
instrument’s quantitative scores or change in 
scores. 
 
† The word ‘true’ must be seen in the context of the CTT, which states that any observation is composed of two 
components – a true score and error associated with the observation. ‘True’ is the average score that would be 
obtained if the scale were given an infinite number of times. It refers only to the consistency of the score, and 
not to its accuracy  
* Interpretability is not considered a measurement property, but an important characteristic of a measurement 
instrument. 
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7.2 Appendix 2- Haemophilia Activities List    
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7.3 Appendix 3- Functional Independence Score in Haemophilia 
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7.4 Appendix 4- HEP-Test-Q  
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7.5 Appendix 5- ISOQOL minimum standard definitions131 
 
 
Measurement 
Property 
 
Recommended minimum standard 
 
Conceptual and 
Measurement 
model  
A PROM should define and describe the concept(s) included as well as the 
participants it targets. In addition, there should be documentation of how the 
concept(s) are organised into a measurement model, including evidence for 
the dimensionality of the measure, how items relate to each measured 
concept, and the relationship among concepts included in the PROM. 
  
Reliability  The reliability of a PROM should preferably be at or above 0.70 for group-
level comparisons, but may be lower if appropriately justified. Reliability 
can be estimated using a variety of methods including internal consistency 
reliability, test–retest reliability, or item response theory. The use of each 
method should be justified. 
  
Validity  
•   Content 
Validity  
 
  
 
  
 
  
 
 
 
•   Construct 
validity  
 
 
 Responsiveness  
  
Should have necessary evidence supporting content validity. This should 
comprise of evidence that patients and experts consider the content of the 
PROM relevant and comprehensive for the concept, population, and aim of 
the measurement application. Documentation of the following should be 
included: (1) qualitative and/or quantitative methods used to solicit and 
confirm attributes (i.e., concepts measured by the items) of the PROM 
relevant to the measurement application; (2) the characteristics of 
participants recruited (e.g., race/ethnicity, culture, age, gender, socio-
economic status, literacy level) with an emphasis on similarities or 
differences with respect to the target population; and (3) justification for the 
recall period for the measurement application 
  
Should have evidence supporting its construct validity, including 
documentation of empirical findings that support predefined hypotheses on 
the expected associations among measures similar or dissimilar to the used 
PROM. 
  
For use in longitudinal research study should have evidence of 
responsiveness. This should include empirical evidence of changes in scores 
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consistent with predefined hypotheses regarding changes in the measured 
PROM in the target population for the research application. 
  
Interpretability of 
scores  
Documentation to support interpretation of scores, including what low and 
high scores represent for the measured concept. 
  
Translation of the 
PROM  
If translated to one or more languages a PROM should have documentation 
of the methods used to translate and evaluate in each language. Studies 
include evidence from qualitative methods (e.g., cognitive testing) to 
evaluate the quality of translations. 
  
Patient and 
Investigator 
Burden  
Must not be overly burdensome for patients or investigators to complete. 
The length of the PROM should be considered in the context of other 
PROMs included in the assessment, the frequency of PROM data 
collection, and the characteristics of the study population. The level of 
literacy require for participants to full comprehend the contents of a PROM, 
it should usually be at a 6th grade education level or lower (i.e., 12 year old 
or lower); however, it should be appropriately justified for the context of the 
proposed application. 
  
 
 
